Research opportunities in bone demineralization, phase 3 by Anderson, S. A. & Cohn, S. H.
1
NASA Contractor Report 3795
q .4..'_ "|
11OI "_OI'S "[l_°'_*ti FiiOl-'* "_I1*%BOOi _-
Final Report Phase III:
Research Opportunities
in Bone Demineralization
• 2, _ , _':_'[
. ... i.75_._.?
CONTRACT NASW-3728
APRIL 1984 _:'"_' E':_--_°_ CE_'!TEF'_
L!BHARY, [_AS;,.
https://ntrs.nasa.gov/search.jsp?R=19840019349 2020-03-20T23:00:34+00:00Z

NASA Contractor Report 3795
Final Report Phase III:
Research Opportunities
in Bone Demineralization
Edited by
S. A. Anderson
Federation of American Societies
for Experimental Biology
Bethesda, Maryland
S. H. Cohn
Brookhaven National Laboratory
Upton, New York
Prepared for
NASA Office of Space Science and Applications
under Contract NASW-3728
N/ A
National Aeronautics
and Space Administration
Scientific and Technical
Information Office
1984

FOREWORD
The Life Sciences Research Office (LSRO), Federation of
American Societies for Experimental Biology (FASEB), provides
scientific assessments of topics in the biomedical sciences.
Reports are based upon comprehensive literature reviews and the
scientific opinions of knowledgeable investigators engaged in
work in specific areas of biology and medicine.
This technical report was developed for the National
Aeronautics and Space Administration (NASA) in accordance with
the provisions of Contract NASW 3728. It was prepared and
edited by Sue Ann Anderson, Ph.D., Staff Scientist, LSRO, with
the advice and assistance of Stanton H. Cohn, Senior Scientist,
Brookhaven National Laboratory.
The LSRO acknowledges the contributions of the investi-
gators and consultants who assisted with this study. The report
reflects the opinions expressed by members of an ad hoc study
group that met at the Federation on May 16 and 17, 1983. The
study participants reviewed a draft of the report and their vari-
ous viewpoints were incorporated into the final report. The
study participants and LSRO accept responsibility for the accu-
racy of the report; however, the naming of these individuals in
Section VIII does not imply that they specifically endorse each
study conclusion.
The report was reviewed and approved by the LSRO Advisory
Committee (which consists of representatives of each constituent
Society of FASEB) under authority delegated by the Executive Com-
mittee of the Federation Board. Upon completion of these review
procedures, the report was approved and transmitted to NASA by
the Executive Director, FASEB.
While this is a report of the Federation of American
Societies for Experimental Biology, it does not necessarily
reflect the opinion of each individual member of the FASEB
constituent Societies.
(dat@) Ke " , Ph D
Director
Life Sciences Research Office
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S UMMARY
Bone demineralization and negative calcium balance
have been reported consistently as a physiological response to
space flight. Additionally, changes in calcium metabolism have
been observed that may be associated with bone loss and a possi-
ble increased risk of fracture. The changes include increased
fecal loss of calcium and hypercalciuria with a possible change in
potential for formation of calcium-containing renal stones. In
United States space flights as long as 3 months and Soviet flights
as long as 7 months, neither loss of bone mineral nor the resultant
hypercalciuria has been associated with impaired functional capaci-
ties of astronauts. However, concern for the health, effectiveness,
and safety of space crews during and following extended or repeated
space flights requires that gaps in knowledge of bone deminerali-
zation be identified and priorities for future research efforts be
indicated.
The processes underlying bone loss in man during space
flight are poorly understood. Histomorphometric studies of bone
changes in rats flown aboard Cosmos biosatellites suggest that
periosteal bone formation is inhibited and endosteal bone resorp-
tion is unchanged in weight-bearing bones in this species. Infor-
mation concerning bone loss in weightlessness has also been ob-
tained in ground-based studies of suspended rats, immobilized
monkeys, and normal human volunteers during bed rest. Comparison
of histomorphometric changes in bone of rats during space flight
with bone changes in the suspendedrat model and with bone changes
in a monkey model indicates that some changes are similar for these
models despite differences in bone growth and remodeling systems
of the two species. Histomorphometric studies of bone changes in
man have not been done during space flight or uncomplicated bed
rest.
Evidence for loss of bone mineral in man during space
flight has been supplied by metabolic balance studies and by non-
invasive measures of bone density changes. These studies indicate
an overall difference between anabolic and catabolic processes but
provide little information concerning the changes occurring in bone
during weightlessness. Metabolic balance studies in man during
bed rest have shown changes in calcium balance generally similar
to those of astronauts during space flight. Increased urinary and
fecal losses of calcium have been reported in each situation. It
has not been determined whether the fecal losses represent increased
endogenous losses or decreased intestinal absorption of calcium.
Noninvasive measures of bone density indicate that preferential
loss of calcium from weight-bearing bone (os calcis) is common to
space flight and bed rest.
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Studies of changes in levels of calcitropic hormones
(parathyroid hormone, vitamin D, and calcitonin) during space
flight and bed rest do not consistently indicate changes of a
magnitude that would ordinarily be associated with increased
mobilization of bone. It is difficult to draw conclusions from
these data, because at the time the measurements were made in
space flight and in published reports of bed-rest studies, assays
for a number of hormones were not well refined. Plasma levels and
urinary excretion of cortisol are increased in man during space
flight and adrenal glands are enlarged in rats following flights
of the Cosmos biosatellites. However, urinary excretion of corti-
sol is nQt increased during bed rest. General systemic effects of
endocrine agents cannot readily explain the local and preferential
demineralization of weight-bearing bones. However, since physio-
logic responses during weightlessness differ from those under
gravity, it may be possible that responses of bone cells to normal
levels of endocrine agents in weightlessness differ from responses
on the ground. This may be particularly evident in weight-bearing
bones that lack their normal gravity-related stimuli.
Trials of countermeasures to prevent bone demineraliza-
tion have been conducted in crews during space flight and, more
extensively, in ground-based studies of human subjects during bed
rest. Exercise during space flight has not completely reversed
negative calcium balance or hypercalciuria. However, there is
some evidence that use of a treadmill during space flight may have
moderated loss of os calcis mineral. In Soviet flights exercise
has reportedly been associated with decreased calcium loss. A num-
ber of levels of weight-bearing and/or exercise regimens have been
tested in ground-based bed-rest studies in the United States in an
effort to determine the amount of physical stress necessary to pre-
vent calcium loss. Of all the protocols evaluated, only controlled
ambulation on a prescribed course for 4 hours completely alleviated
negative calcium balance. Dietary intervention (supplementation
of fluoride or supplementation of calcium and phosphorus) did not
reverse hypercalciuria or negative calcium balance over a long
period of bed rest. A combination of calcium and phosphorus sup-
plements, longitudinal compression and administration of synthetic
salmon calcitonin was partially effective for a shorter period;
however, administration of synthetic salmon calcitonin or longitu-
dinal compression alone was not effective. Diphosphonates (EHDP
or clodronate) administered to normal subjects during bed rest
have been the most effective pharmacologic agents tested. How-
ever, side effects of these particular compounds contraindicate
their further use.
The following report comprises an overview of bone demin-
eralization during space flight, observations of the ad hoc Working
Group on the NASA Biomedical Research Program in Bone Demineralization
and experiments related to boneloss planned for Spacelab flights,
and suggestions for further research. The observations of the ad hoc
Working Group focused upon the following topics: (I) pathogenesis
vi
of bone demineralization, (2) potential for occurrence of renal
stones consequent to prolonged hypercalciuria, (3) development of
appropriate ground-based and inflight models to study bone demin-
eralization, (4) integration of research efforts, and (5) develop-
ment of effective countermeasures. Priorities for further research
are indicated.
vii
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I. INTRODUCTION
Physiological adjustments to the space environment involve
most tissues and organs, including the nervous, cardiovascular,
muscular, and skeletal systems. The responses, with the exception
of space motion sickness, have not resulted in impaired functioning
of crew members during flight. Details of some physiological
changes during space flight and readjustment to the Earth's envi-
ronment are described by Levy and Talbot (1983), Nicogossian and
Parker (1982), Talbot (1983), Thornton and Rummel (1977), Smith
et al. (1977), and Whedon et al. (1979).
Low bone mass is recognized as a factor in the complex
etiology of fracture (Johnston and Epstein, 1981). Thus, bone
demineralization during weightlessness is a physiological change
that may have the potential to cause both chronic and acute prob-
lems, particularly in association with extended or repeated space
missions. Other problems that may be associated with the loss of
calcium from bone include increased fecal loss of calcium and
hypercalciuria, with a possible change in potential for formation
of calcium-containing renal stones.
Changes in calcium metabolism and skeletal mineral con-
tent associated with space flight have been assessed in man by
metabolic balance techniques and 125I gamma ray transmission
scanning of bone. Total body calcium losses average about 0.3 to
0.4_/mo during space flight (Whedon et al., 1977). Os calcis (a
weight-bearing bone) loses about 5_ of its mass per month during
space flight while radius and ulna (nonweight-bearing bones) show
no measurable loss (Smith et al., 1977; Vogel and Whittle, 1976).
Similar bone losses (5 to 8_) were reported in os calcis following
the 175-day Salyut-Soyuz flight (Oganov, 1981a). Bone loss appears
reversible following flights as long as 84 days (Smith et al.,
1977) but reversibility of bone loss following more extended or
repeated space missions remains to be determined.
Effects of hypercalciuria have received less research
attention than the loss of bone calcium. Approximately 75 to 80_
of renal stones contain calcium. However, a change in propensity
for renal stone formation will depend not only on increased urinary
concentration of calcium but also on such factors as urinary pH,
concentrations of inorganic constituents (sodium, magnesium, potas-
sium, and phosphorus), concentrations of organic compounds (uric
acid, citrate, and oxalate), and crystallization characteristics
(Coe and Favus, 1980; Pak, 1981; Pak et al., 1978). Development
of renal stones could be a more immediate problem than bone demin-
eralization for susceptible crew members during a space mission;
however, in United States space flights as long as 3 months and
Soviet flights as long as 7 months, neither loss of bone mineral
nor the resultant hypercalciuria has been reported to impair
functional capacities of astronauts.
NASA's policy of providing preventive medical care for
persons exposed to the space environment requires that all neces-
sary precautions be taken to prevent or counteract any adaptive
responses to space flight unless they are shown to be beneficial.
Therefore, despite the lack of evidence that bone demineralization
during exposure to weightlessness is associated with adverse
health effects during or following space flight, NASA must regard
bone demineralization and the associated alterations in calcium
metabolism as a significant biomedical problem of space flight.
Concern for the well-being, effectiveness, and safety of crew
members during and following space missions of extended duration
dictates that gaps in knowledge of bone demineralization be identi-
fied as research opportunities. In order to enhance its research
and analysis programming on bone demineralization during space
flight, NASA requested that the Life Sciences Research Office
(LSRO) of the Federation of American Societies for Experimental
Biology (FASEB) review and evaluate its ongoing research effort
and provide suggestions for future directions for research in this
area. This task was performed with the guidance of the ad hoc
Working Group of scientists listed in Section VIII.
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II. OBJECTIVES AND SCOPE OF THE STUDY
The objectives of the LSRO ad hoc review of bone demin-
eralization during space flight are:
(i) to review extant knowledge of the subject;
(2) to examine NASA's current and projected research
program;
(3) to identify significant gaps in essential knowledge;
(4) to formulate additional suggestions for future
research for consideration by NASA; and
(5) to produce a documented report of the foregoing
items that can be used for NASA program planning
for future research.
The programs considered by the ad hoc Working Group were
the in-house and extramural ground-based research efforts of NASA's
Biomedical Research Program and the experiments related to bone
loss planned for Spacelab flights 2 and 4 scheduled for 1985 and
1986, respectively. Among the resources examined for information
relating to these endeavors were an extensive published scientific
and technical literature, runpublished data of the United States
and Soviet space programs, the NASA Research and Technology Objec-
tives and Plans (RTOPs) on bone demineralization, Research and
Technology Resumes (RTRs) on bone demineralization, and summaries
of inflight experiments related to bone loss planned for the Space-
lab missions 2 and 4.
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III. AN OVERVIEW OF BONE DEMINERALIZATION IN SPACE FLIGHT
This section summarizes research findings concerning bone
loss associated with space flight and with ground-based models
simulating weightlessness. Extensive literature exists concerning
bone loss in patients with various forms of osteoporosis or those
immobilized for therapeutic purposes. Studies of these conditions
have not been included in this overview, because their complex and
diverse etiologies may not apply to bone loss observed in healthy
individuals during uncomplicated bed rest or space flight. Aspects
of calcium and bone loss in osteoporosis and immobilization have
been summarized by Johnston and Epstein (1981), Krane and Holick
(1980), and Parfitt (1983).
A. DEFINITION
Bone demineralization is defined as the excessive elimina-
tion of mineral or inorganic salts from the skeleton. Accelerated
loss of bone mineral has been consistently reported as an effect
of space flight (Rambaut et al., 1975a; Smith et al., 1977). Over-
all, bone and total calcium losses seem to resemble those of healthy
subjects during ground-based bed rest: urinary and fecal calcium
excretion are increased, calcium balance is negative, and calcium
seems to be lost preferentially from weight-bearing bone (Deitrick
et al., 1948; Donaldson et al., 1970; Rambaut et al., 1975a,b;
Smith et al., 1977; Whedon et al., 1977).
Loss of bone mineral has also been associated with disease
states including osteoporosis. Krane and Holick (1980) define
osteoporosis as "a group of diseases of diverse etiology which are
characterized by a reduction in the mass of bone per unit volume
to a level below that required for adequate mechanical support
function. The reduction in mass is not accompanied by a signifi-
cant reduction in the ratio of the mineral to the organic phase,
nor by any reproducible abnormali-ty in the structure of either the
mineral or the organic matrix." Osteoporosis is generally regarded
as the response of bone to many influences, some of which affect
bone by altering calcium homeostasis and others by acting on bone
directly (Riggs et al., 1981). These influences include dietary
inadequacies, progressive impairment of calcium absorption, inac-
tivity, and hormonal imbalances. Osteoporosis is a common feature
of many disorders or conditions. The form that seems most similar
to bone demineralization during space flight is disuse osteoporosis
which develops in healthy persons during immobilization. It is
unclear how mechanical forces influence the processes of bone
modeling and remodeling, but, according to Lanyon (1981), "it is
reasonable to assume that the strains resulting from the commonly
encountered loading situations of repetitive coordinated functional
activity provide a continuing stimulus."
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Bone loss has been evaluated in many studies of patients
immobilized as a result of spinal cord injuries, major lower limb
fractures, and poliomyelitis or other nontraumatic causes of exten-
sive muscle paralysis. However, the stress, trauma, and denervation
associated with these conditions may produce a type of disuse bone
loss that is dissimilar in some respects to that observed in healthy
individuals during uncomplicated bed rest (Parfitt, 1981).
B. CALCIUM RESPONSES TO WEIGHTLESSNESS AND SIMULATED
WEIGHTLESSNESS
i. Calcium losses in man durin_ space flight
Metabolic balance studies conducted during space
flights indicate that exposure to weightlessness results in nega-
tive balances of calcium and phosphorus as well as magnesium and
nitrogen (Lutwak et al., 1969; Rambaut et al., 1975b; _edon
et al., 1977). The earliest observation of changes in calcium and
phosphorus balances occurred during the 14-day Gemini VII orbital
space flight (Lutwak et al., 1969). Although interpretation of
the data was qualified because of technical difficulties, calcium
balances in the two astronauts became less positive than pre- and
postflight values by the end of the first week of flight and phos-
phorus balances were negative throughout the flight (Lutwak et al.,
1969).
More extensive metabolic data were collected for 5 days
during the 12 day Apollo 17 flight and compared with data gathered
on the Apollo crewmen for 5 days approximately 2 months prior to
the flight (Rambaut et al., 1975b). Each of the three crewmen was
in positive calcium balance (318, 360, and 235 mg/d) during the
baseline period. Inflight mean daily calcium intake was 674 mg.
Urinary excretion of calcium differed little from baseline values
but fecal losses were two to three times greater during flight than
before flight. Calcium balances during flight were +18, -199, and
-37 mg/d, apparently caused by increased fecal Ibsses. In a par-
tial metabolic study conducted during the ll-day Apollo 16 flight
(Rambaut et al., 1975b), fecal calcium losses greatly in excess of
intake were also recorded for each of the three crewmen. Similar
results regarding fecal calcium excretion have been reported in
association with intense stress (Malm, 1958; Ohlson and Stearns,
1959; Roberts et al., 1948), and in patients with osteoporosis
(Gallagher et al., 1973).
Phosphorus intake was approximately two times the calcium
intake and fell somewhat during the Apollo 17 flight from preflight
intakes. Urinary and fecal excretion of phosphorus increased
during flight, bringing each of the crewmen into negative balance
(-117, -507, and -325 mg/d) (Rambaut et al., 1975b).
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Calcium and phosphorus balances were also measured in
the nine astronauts participating in Skylab missions 2, 3, and 4
of 28-, 59-, and 84-days duration, respectively. Mean calcium and
phosphorus balances for the six astronauts in Skylab missions 2
and 3 fell from positive balances preflight to negative values
inflight and returned to positive values postflight (Whedon, 1979;
Whedon et al., 1977). Calcium intakes were reported as nearly con-
stant before, during, and after the flights. The mean daily die-
tary calcium intake of the Commander of Skylab 3, considered
representative for the members of that mission, was 725 mg pre-
flight, 729 mg inflight, and 742 mg postflight (Whedon et al.,
1977).
The mean shift in calcium balance for the six astronauts
of Skylab flights 2 and 3 from the preflight control periods (18
and 28 days) to the last 16 to 18 days during flight was -184 mg/d.
The mean calcium balance during the second month in flight for the
three crewmen of the 59-day Skylab 3 flight was -140 mg/d. Phos-
phorus balance was also negative during Skylab flights 2 and 3:
in Skylab 2 the mean shift from preflight values was about -400 mg/d
while in Skylab 3 it was -222 mg/d (Whedon et al., 1977).
Postflight, phosphorus balances of all and calcium bal-
ances of two of the three astronauts from Skylab 2 returned to pre-
flight values within 17 days. For the three Skylab 4 astronauts,
calcium balances became less negative, but had not returned to pre-
flight positive balances by the end of the 18-day postflight
evaluation period (Whedon et al., 1979).
Urinary excretion of calcium during the three Skylab
flights increased steadily during the first 2 to 4 weeks of flight
until losses were approximately 80 to i00_ greater than preflight
levels. Urinary calcium excretion remained at these elevated levels
throughout flight (Whedon et al., 1977). Considerable inter-indi-
vidual variation in the degree of hypercalciuria was present, but
the overall trends followed the same patterns for all of the astro-
nauts. Urinary phosphorus excretion increased markedly during
flight. Urinary excretion of calcium and phosphorus followed the
same pattern of increase and was of the same magnitude as that of
immobilized healthy male subjects (Deitrick et al., 1948; Donaldson
et al., 1970; Whedon et al., 1977). Urinary excretion of hydroxy-
proline and total and nonglycosylated hydroxylysine was elevated
during flight for the nine crew members of the Skylab flights (Leach
and Rambaut, 1975, 1977; Whedon et al., 1977). The mean increase
in hydroxyproline excretion was 30_, although marked individual
differences were noted (Whedon et al., 1977; Whedon, 1982). Inves-
tigators in the Soviet Union have also reported increased excre-
tion of calcium during space flight (Biryukov and Krasnykh, 1970;
Gazenko et al., 1980). During the postflight recovery periods
urinary calcium excretion returned toward preflight baseline
levels.
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Urinary excretion of uric acid was decreased during flight
for most of the crew members of the Skylab missions (Leach and
Rambaut, 1977). Plasma uric acid levels were not measured during
flight but were significantly decreased postflight, confirming
findings reported following the Apollo flights (Leach and Rambaut,
1975; Rambaut et al., 1975b). Factors responsible for the low
levels of uric acid in plasma were not readily apparent.
In contrast to the very large increases in fecal calcium
and phosphorus excretion reported for the Apollo 17 astronauts
(Rambaut et al., 1975b), smaller overall increases in fecal calcium
and phosphorus losses were observed in the crewmen of the Skylab
flights (Rambaut et al., 1979; Whedon et al., 1977). When fecal
calcium losses were expressed as a function of flight duration,
however_ a different excretion pattern became apparent. During
the early phases of flight fecal calcium excretion decreased to
levels below preflight values, then rose steadily for the remainder
of the flight and showed no tendency to plateau (Rambaut and
Johnston, 1979). The investigators suggested that the continuous
increase in fecal calcium excretion during space flight represented
the major route of calcium loss and might represent either progres-
sive malabsorption of calcium or increased losses of endogenous
calcium. Another analysis of these data indicated the changes
in fecal calcium excretion, net calcium absorption, and relative
calcium absorption (net absorption expressed as a percentage of
dietary intake) were not statistically significant, thereby sug-
gesting that the negative calcium balance of space flight resulted
from an increase in urinary calcium excretion (Parfitt, 1981).
The amount of calcium lost during each month of space
flight was calculated to represent about 0.3 to 0.4_ of total body
calcium. An extrapolation to a S-month space flight indicated that
2 to 3_ of total body calcium would be lost by astronauts during
that length of time (Bricker, 1979; Whedon et al., 1977). However,
an extrapolation based on the analysis of Rambaut and Johnston
(1979) predicted that the average quantity of calcium lost in one
year of space flight would be over 300 g or 25_ of the overall
body pool of calcium (1250 g). Parfitt (1981) calculated the rela-
tive loss of cortical and trabecular bone to be 0.5% and 5.0_,
respectively, based on his analysis of the calcium $oss data and
on the assumption that bone loss is partitioned between cortical
and trabecular bone in proportion to their rates of turnover.
Measurements of bone density corroborate the evidence of
bone calcium loss implied by balance studies during space flight.
Data collected by radiographic densitometry before and after the
early Gemini and Soyuz missions suggested large losses of bone
density in os calcis, radius, and ulna in short-term flights of
4 to 14 days (Mack and Lachance, 1967). However, reevaluation of
some of these data indicated significant overestimates of the
losses (Vose, 1974). In these very short flights, the losses of
bone mineral were likely very slight.
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Mineral content of the radius, ulna, and os calcis of 18
astronauts was determined by photon absorptiometry immediately
before and after Apollo 14, 15, and 16 missions and the Skylab 2,
3, and 4 flights. This method was considered a more reliable esti-
mate of bone mineral loss (Rambaut et al., 1972). Two crewmen
from the Apollo 15 mission (14 days) showed loss of os calcis min-
eral. No significant mineral losses were reported in the radius or
ulna of the crewmen on the Apollo missions (Rambaut et al., 1975a).
No bone mineral losses were detected during the Skylab 2 mission
(28 days); however, significant losses in os calcis mineral (-7.4_,
-4.59, and -7.9_) occurred in three of the six crewmen of the Sky-
lab 3 and 4 missions. These crewmen also had the largest increases
in urinary calcium losses and the greatest negative shifts in cal-
cium balances (Smith et al., 1977). No losses were detected in
radius or ulna. Similar mineral losses (5 to 8_) from os calcis
were reported for cosmonauts following the 175-day Salyut-Soyuz
flight (Oganov, 1981a).
It is understood that a joint program between the United
States and the Soviet Union is underway to evaluate by computed
tomography (CT) techniques mineral content of vertebral columns of
the Soviet cosmonauts on the 211-day flight (Cann et al., 1983).
In a previous study of vertebral density of Soviet cosmonauts and
bed-rested subjects, Cann (1981) reported that spinal bone loss
appeared to correlate well with calcium balance data.
Little is known concerning degradation of organic bone
matrix during space flight. Urinary excretion of total hydroxypro-
line, peptide-bound hydroxyproline or hydroxylysine glycosides was
increased in astronauts during space flight, but to a lesser extent
than in quadriplegic patients (Claus-Walker et al., 1977; Rambaut
and Johnston, 1979; Rambaut et al., 1979). Analysis of autopsy
samples of os calcis of three cosmonauts of Salyut-i indicated no
abnormalities in amino acids, glycoprotein, or organic matrix con-
tent after 28 days of space flight (Prokhonchukov and Leont'yev,
1980; Prokhonchukov et al., 1980).
The question of reversibility of the loss of bone mineral
during space flight has not been completely resolved. Os calcis
mineral content of the Skylab 3 crewman (59-day flight) was regained
by 87 days postflight. However, os calcis mineral of the two Sky-
lab 4 crewmen had not returned to preflight values by 95 days post-
flight (Smith et al., 1977). Os calcis mineral content measured 5
years following the Skylab program was significantly lower in the
nine crew members participating in space flights than in eight
back-up counterparts (Tilton et al., 1980). The investigators were
unsure of the clinical significance of this finding and advised
cautious interpretation of the data. Although low bone mass has
been recognized as a factor contributing to fracture, many individ-
uals with low bone mass do not experience bone breakage, whereas
some persons with higher than normal bone mass for age do develop
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fractures (Johnston and Epstein, 1981). It has been suggested
that even large initial deficits resulting from increased bone
turnover may be completely reversible with no intervention other
than removal of the stimulus responsible for the increased activ-
ities and turnover (Parfitt, 1981).
2. Calcium losses in man durin_ simulated weightlessness
Bed-rest studies of healthy men have been used as
the ground-based simulation of weightlessness for evaluation of
mineral metabolism during space flight. Protocols for bed-rest
studies in the United States have included horizontal recumbency
with or without partial raising of the upper body for meals or
reading, with or without bathroom privileges, and with use of
partial body casts for complete immobilization. Anti-orthostatic
(6 ° head-down tilt) bed rest is the position described by cosmo-
nauts as most closely approximating their sensation of head full-
ness experienced during space flight. This protocol may be
employed during future ground-based studies of bone demineraliza-
tion in the United States.
During the early phases of bed rest, plasma ionized cal-
cium showed very small fluctuations and parathyroid hormone (PTH)
levels were normal or below baseline values (Heath et al., 1972).
However, it was reported in studies from the U.S.S.R. that plasma
concentrations of calcium and PTH were increased in bed-rest
studies lasting 3 to 6 months (Grigor'yev, 1981). Urinary calcium
excretion of healthy persons begins to rise immediately with onset
of bed rest (Deitrick et al., 1948; Donaldson et al., 1970; Hulley
et al., 1971). In these studies, urinary calcium concentrations
peaked at about 6 to 7 weeks after initiation of bed rest and then
began to subside, but hypercalciuria persisted throughout bed-rest
periods as long as 36 weeks.
Hypercalciuria and development of renal stones have been
associated with immobilization in patients (Albright et al., 1941;
Leadbetter et al., 1945; Tori and Kewalramani, 1978). Parfitt
(1983) listed several factors associated with immobilization
including impaired drainage of the kidneys, increased phosphate
excretion, and increased urinary pH which might increase the risk
of development of renal stones during uncomplicated bed rest and
possibly space flight.
Fecal calcium excretion was elevated throughout the studies
of Donaldson et al. (1970) and Hulley et al. (1971), suggesting
either decreased absorption or increased endogenous loss of calcium
into the gastrointestinal tract. The sources of the increased
fecal calcium excretion have not been ascertained. Two experimen-
tal approaches suggest different origins of the calcium. Studies
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of calcium kinetics suggestedincreasedsecretion of endogenous
calcium into the gut; however, measurement of intestinal calcium
absorption after 5 weeks of bed rest indicated decreased, increased,
or unchanged absorption among the subjects (Lockwood et al., 1975).
Study of calcium kinetics in patients immobilized by poliomyelitis
suggested that absolute absorption and efficiency of absorption of
calcium were greatly depressed during the acute development stage
but not the chronic, stable stage of disuse osteoporosis (Heaney,
1962).
Calcium balance during 36 weeks of bed rest was about
-200 mg/d, a loss of total body calcium of about 0.5_ each month or
4.2_ for the entire period. Mean phosphorus balance was -34 mg/d.
Urinary excretion of hydroxyproline peaked during the second month
of bed rest with a mean excretion level for the entire period
approximately 8_ above baseline levels (Donaldson et al., 1970).
Schneideret al., (1981a)reportedthat calcium balance in older
male subjects (35 to 45 years of age) was similar to that of
younger subjects (ages 19 to 35 years).
Measurements of bone mineral content during bed rest by
125I gamma ray transmission scanning showed no losses of bone min-
eral in the radius, but substantial losses of mineral content
(25 to 40_) in the weight-bearing os calcis during periods of 24 to
36 weeks (Donaldson et al., 1970; Hulley et al., 1971). This rate
of loss from the os calcis (approximately 4_ each month) was dis-
proportionately greater than the overall rate of loss of body cal-
cium (0.5_/mo) but rates of mineral loss of other weight-bearing
bones were not measured. Calculations by Rambaut and Johnston
(1979) indicated that loss of calcium from the calcaneus accounted
for only a small proportion of the total amount of calcium lost.
Data of Hesp et al. (1982) indicated differences in regional bone
density measurements compared with total body calcium in osteo-
porosis. Dual-photon (153Gd) absorptiometry measures of bone
mineral of the lumbar vertebrae indicated a loss of 0.9_/wk during
bed rest periods of ii to 61 days (mean 27 days), suggesting a
rate of loss of bone mineral from the lumbar vertebrae similar to
that of the os calcis during bed rest (Kr_Iner and Taft, 1983).
However, no significant changes in urinary excretion of calcium or
phosphorus were reported in this study.
When zero balance was used as the baseline for calculating
change in calcium balance during space flight, values reported for
urinary loss of calcium, negative calcium balance, and loss of
os calcis mineral by astronauts during exposure to weightlessness
were within two standard deviations of the means for these parame-
ters measured in healthy subjects during bed rest (Parfitt, 1981).
An alternate method for calculation of the calcium loss in the Sky-
lab astronauts utilized the positive balances observed preflight
as the baseline for computing the changes in calcium metabolism
occurring during space flight, thereby maximizing the changes
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observed (Rambaut and Johnston, 1979). Based on these calculations,
Rambaut and Johnston (1979) concluded that bone demineralization
during space flight was more severe than predicted on the basis of
observations of immobilized, bed-rested, or paralyzed subjects and
suggested that the process might not be totally reversible.
The changes in calcium balance and in mineral content of
os calcis and lumbar vertebrae of subjects during voluntary or
therapeutic bed rest appear reversible upon reambulation (Donaldson
et al., 1970; Hulley et al., 1971; Kr_iner and Taft, 1983).
Donaldson et al. (1970) reported that remineralization of os calcis
began immediately upon reambulation and that remineralization
occurred at a rate similar to the loss. Initial values for bone
density were regained by 36 weeks of reambulation. Following a
bed-rest study of 24- to 30-weeks duration, calcium balances became
positive during the first month of reambulation and remineraliza-
tion of the os calcis occurred within I0 to 20 weeks (Hulley et al.,
1971). Vertebral losses were nearly restored 4 months after thera-
peutic bed rest of ii to 61 days (Kr_Iner and Taft, 1983). How-
ever, Rambaut and Johnston (1979) referred to unpublished studies
in which calcium balance returned to zero balance in middle-aged
men before all bone mineral could have been restored.
Studies of calcium kinetics in healthy subjects during
bed rest suggested that the rates of bone accretion and resorption
were both increased, with a greater increase in bone resorption
(Lockwood et al., 1975). Similar findings were reported in polio-
myelitis patients with acutely developing disuse osteoporosis; how-
ever, bone formation and resorption rates were normal or slightly
low in patients with chronic, stable disuse osteoporosis (Heaney,
1962). Changes in bone histomorphometry have not been measured in
studies of healthy subjects during uncomplicated bed rest. The
applicability of measurements of skeletal histomorphometry to the
study of bone changes was reviewed by Meunier (1983). Quantitative
histological data are available from iliac crest biopsies of 28
patients immobilized by spinal cord trauma, fractures, Schneider's
syndrome, or cervical myelopathy (M_naire et al., 1974). Bone
samples used as control comparisons were obtained at autopsy from
236 accident victims. Trabecular bone volume of the immobilized
patients was less than that of the control samples. In the
immobilized patients, trabecular bone volume decreased by an aver-
age of 33% prior to the 25th week of immobilization, after which
time it appeared to become constant at a new, lower steady state
value. The trabecular osteoclastic resorption surface varied
during the period of immobilization. During the first 16 weeks
following trauma it increased from normal (3_) to a high (5.3%)
value. From 16 to 40 weeks the resorption surface decreased to
normal values and stabilized at this level. The periosteocytic
lacunae also enlarged temporarily after 12 weeks of immobilization.
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Osteoblastic bone formation was greatly decreased and the
internal and external cortices thinned about 50_ during the 40 weeks
following onset of immobilization (Minaire et al., 1974). Rela-
tive osteoid volume of cancellous bone decreased during the early
part of immobilization, then rose to normal values, and eventually
stabilized at values slightly below normal. The calcification rate
as measured by tetracycline labeling was also very slow. Urinary
excretion of calcium and hydroxyproline was elevated. Plasma cal-
cium concentration remained within the normal range. The investi-
gators suggested several possible interpretations of these findings
in terms of changes in bone cell metabolism (Minaire et al., 1974).
C. ENDOCRINE RESPONSES TO WEIGHTLESSNESS AND
SIMULATED WEIGHTLESSNESS
Bone metabolism is regulated in part by endocrine factors.
Several recent comprehensive reviews should be consulted for a
detailed discussion of specific roles of hormones and their mecha-
nisms of control of bone metabolism (Raisz, 1980; Raisz and Kream,
1983a,b; Raisz and Lorenzo, 1980).
i. Endocrine responses in man during space flight
Endocrine responses were measured in astronauts
before and after the Apollo flights and during Skylab missions 2,
3, and 4 and for at least 21 days before flight and 17 days after
the Skylab missions (Leach and Rambaut, 1977; Leach et al., 1975;
Whedon et al., 1979). Calcitropic hormones showed no changes that
would explain satisfactorily the mobilization of bone mineral
during space flight. PTH levels fluctuated above and below pre-
flight values during the Skylab flights. There was a tendency
towards a slight increase in PTH level during the third month of
the Skylab 4 flight; however, plasma samples from only three of
the nine Skylab astronauts were available for these analyses and
the increases were not statistically significant (Leach and
Rambaut, 1975). Similarly, no change was noted in serum PTH con-
centrations prior to or following the Apollo missions (Leach
et al., 1975). Plasma levels of 25-hydroxycholecalciferol were
not different before and after the Skylab flights of 28 and
59 days; however, plasma 25-hydroxycholecalciferol levels were
decreased by about 9_ immediately postflight in the Skylab 4 astro-
nauts exposed to weighZlessness for 84 days. Calcitonin levels in
plasma were too low to be measured by the assay used and therefore
were considered not elevated to any clinically significant extent
(Leach and Rambaut, 1975, 1977; Whedon et al., 1979). Total con-
centrations of calcium and phosphate in plasma rose slightly but
significantly during the Skylab flights, returning to preflight
values during the postflight periods (Leach and Rambaut, 1975).
During space flight plasma calcium and phosphate levels were with-
in ranges considered normal (Guyton, 1981).
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Changes in urinary excretion of adrenal hormones were
observed following the Mercury, Gemini, and Apollo flights (Leach,
1971). Plasma and urinary levels of adrenal hormones were measured
during the Skylab flights. Glucocorticoids are of particular
interest because of their direct and indirect effects on calcium
metabolsim (Raisz, 1980). Evidence indicates interactions of glu-
cocorticoids with PTH (Chen and Feldman, 1979; Wong, 1979) and
vitamin D (Chesney et al., 1978; Hahn et al., 1979; Slovik et al.,
1980).
Plasma adrenocorticotrophic hormone (ACTH) concentrations
were generally decreased during and after flight, but adrenocortical
hormones followed no consistent patterns during space flight.
Plasma and urinary cortisol concentrations were elevated above
baseline levels throughout the three Skylab flights, returning
towards baseline levels postflight (Leach and Rambaut, 1975, 1977;
Leach et al., 1975, 1976). Urinary but not plasma cortisol levels
were elevated following the Apollo missions (Leach et al., 1975).
Urinary excretion of 17-hydroxycortisone was elevated in the three
crew members of the Apollo 17 flight. Total urinary 17-hydroxy-
corticosteroids did not change or decreased only slightly during
the flight; however, the proportions of individual components
varied, with decreases in pregnanetriol and tetrahydrocortisone
and a slight increase in tetrahydrocortisol during the Skylab
flights (Leach and Rambaut, 1975; 1977). Postflight, a significant
decrease of total urinary 17-hydroxycorticosteroids was observed
for astronauts from both the Skylab and Apollo series (Leach and
Rambaut, 1977; Leach et al., 1975, 1976). Urinary excretion of
total 17-ketosteroids rose with increases in androsterone and
etiocholanolone excretion specifically (Leach and Rambaut, 1977).
Following the Apollo missions, however, urinary excretion of
androsterone and etiocholanolone fell by 49 and 35g, respectively
(Leach et al., 1975). A slight downward trend was reported in uri-
nary excretion of epinephrine and norepinephrine inflight; how-
ever, both showed little change (Apollo) or tended to increase
immediately postflight (Skylab) (Leach and Rambaut, 1977; Leach
et al., 1975, 1976; Whedon et al., 1979).
Other hormones indirectly implicated in calcium metabolism
were measured as a part of the Apollo and Skylab studies. Thyroid
hormone concentrations showed changes postflight when compared to
preflight values. Thyroid stimulating hormone (TSH) and thyroxine
(T4) concentrations in plasma were increased; however, no change
occurred in tri-iodothyronine (T3) uptake postflight (Leach and
Rambaut, 1977; Leach et al., 1975). Plasma human growth hormone
increased significantly on the first day of flight and showed an
even greater increase following flight (Leach et al., 1975; Whedon
et al., 1979). For the Skylab astronauts fasting plasma insulin
concentrations varied during the first month of flight, then
decreased by 20 to 60_ for the remainder of the longer flights.
However, fasting plasma glucose levels did not change during the
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first month of flight and fell only about 5_ during the remainder
of the longer flights. After the Apollo and Skylab flights, fasting
plasma insulin levels were somewhat elevated, but plasma glucose
increased only slightly (Leach and Rambaut, 1977; Leach et al.,
1975; Whedon er al., 1979).
Some measures of endocrine changes during space flight
are also available from the two cosmonauts of a U.S.S.R. 63-day
flight, Salyut-4. Increased concentrations of total 17-hydroxy-
corticosteroids and norepinephrine in urine and TSH in blood were
reported (Tigranyan and Ushakov, 1978).
In summary, plasma levels of the calcitropic hormones
(PTH, 25-hydroxycholecalciferol, and calcitonin) measured to date
in crew members during space flights have not shown changes that
would account for the mobilization of bone calcium. Plasma levels
and urinary excretion of other hormones related to calcium metabo-
lism (cortisol, insulin, and human growth hormone) increased during
space flight. The role of these hormones in calcium metabolism of
man during space flight has not been established.
Experiments related to study of bone loss are planned for
upcoming Spacelab flights (See Appendix B). Plasma levels of
1,25-dihydroxycholecalciferol and other vitamin D metabolites will
be measured in the astronauts of the Spacelab 2 mission scheduled
for 1985. A more comprehensive study of factors affecting calcium
metabolism is planned for Spacelab 4. The crew of that flight will
serve as experimental subjects. This study will combine investiga-
tion of changes in plasma levels of the calcitropic hormones, PTH
(intact, N-terminal, and C-terminal assays), calcitonin, and the
vitamin D metabolites (25-hydroxycholecalciferol, 1,25-dihydroxy-
cholecalciferol, and 24,25-dihydroxycholecalciferol) with an
examination of changes in intestinal calcium absorption done by a
dual-isotope technique, using stable calcium isotopes. These
studies should provide information concerning primary defects in
renal or intestinal handling of calcium, on rates of total body
calcium turnover, and, by inference, information concerning early
changes in bone turnover.
2. Endocrine responses in man during simulated
weightlessness
In a short-term (lO-day) study of male and female
subjects in the age ranges 36-45, 46-55, and 56-65 years, bed rest
was associated with different effects on urinary excretion of hor-
mones among the age and sex groupings. Calcitropic hormones were
not measured in the study; however, urinary excretion of cortisol
was found to be essentially unchanged after bed rest (LaRochelle
et al., 1982).
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In a long-term experiment involving six subjects, Hantman
et al. (1973) noted that PTH levels did not change in a consistent
manner during 19 weeks of bed rest. Schneider (1981) also reported
that studies of PTH concentrations during several bed-rest studies
were inconclusive and attributed this in part to the type of PTH
assay performed. Calcitonin and 1,25-dihydroxycholecalciferol con-
centrations measured in normal volunteers during bed rest are not
yet available. However, in 14 patients immobilized by traumatic
spinal cord injury and fed a diet containing 400 mg calcium and
800 mg phosphorus, serum levels of 1,25-dihydroxycholecalciferol,
immunoreactive PTH, and nephrogenous cyclic AMP were markedly
reduced. Serum levels of 25-hydroxycholecalciferol and calcium
were normal and urinary excretion of calcium was elevated. None
of these patients had a prior history of nephrolithiasis, hypercal-
ciuria_ or metabolic bone disease (Stewart et al., 1982).
Some indicators of adrenal function have been measured
during bed rest. Leach et al. (1973) reported that urinary excre-
tion of epinephrine and norepinephrine fell slightly and that
exercise prevented the decrease in norepinephrine excretion.
Later, Sandler et al. (1983) reported that excretion of norepineph-
rine, but not epinephrine, was significantly increased during bed
rest. Excretion of 17-hydroxysteroids (Sandler et al., 1983) and
hydrocortisone (Leach et al., 1973) showed a slight but nonsignifi-
cant tendency to be elevated. Urinary excretion of cortisol was
not significantly increased (LaRochelle et al., 1982) in contrast
to higher levels reported in plasma and urine of astronauts during
space flight (Leach and Rambaut, 1976; Leach et al., 1977).
Insulin-glucose relationships were abnormal during bed
rest. Baseline glucose and insulin levels remained normal but, by
the first week of bed rest, administration of a glucose challenge
provoked an exaggerated insulin response which persisted as long
as 2 weeks of recovery following bed rest (Dolkas and Greenberg,
1977; Lipman et al., 1970a; Sandler et al., 1983). A linear
association between urinary calcium excretion and insulin levels
has been reported (Allen et al., 1981). Production of the insulin
antagonists, glucagon and growth hormone, changed little during
bed rest (Lipman et al., 1970b; Pawlson et al., 1968).
D. MECHANISMS OF BONE LOSS
I. Studies during space flight
Information concerning mechanisms of bone loss and
histologic changes in bone during weightlessness has been derived
from studies of rats flown aboard spacecraft, ground-based immobi-
lized animals (suspended rats or restrained monkeys), and patients
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exhibiting bone loss following spinal cord injury. See Section
III-B (p. 6) for a description of histomorphometric findings in
trauma patients. Histologic changes in bone during exposure to
weightlessness and the underlying causes thereof have not been
studied in man or in an animal model (e.g., monkeys, dogs, minia-
ture pigs) having a bone remodeling system similar to that of man.
However, some histomorphometric changes in bones of rats flown
aboard spacecraft are similar to those reported for restrained
monkeys in ground-based studies (See Section III-D, p. 19).
Collaborative studies between the U.S. and U.S.S.R. of
skeletally immature male rats flown onboard Cosmos biosatellites
782, 936, and 1129 have been useful in the investigation of some
of the changes in bone occurring during space flight. In compari-
son to ground-based control rats, parameters associated with peri-
osteal bone formation were decreased significantly in tibiae of
rats flown for 19 days onboard the Cosmos 782 and 938 biosatel-
lites. Parameters associated with bone resorption, longitudinal
growth, and bone mineral density showed no significant changes.
Arrest lines at both the periosteal and endosteal surfaces implied
that bone growth stopped completely in the flight animals. A re-
bound effect was observed in bone formation parameters in the
flight rats during a 26-day postflight period (Morey and Baylink,
1978; Turner et al., 1979; Wronski et al., 1980).
Direct measurement of resorption of bone from the rib cage
of space-flown rats suggested that mobilization of bone mineral
continued at the same rate as in ground-based synchronous control
rats for the first I0 to 12 days of flight. Study of kinetics of
bone resorption measured as calcium excretion suggested that break-
down subsequently decreased, falling to a level 20 to 25% below
that of the controls at the end of flight. However, normalization
of resorption rates by calcium turnover indicated that the decrease
was probably secondary to an overall slowdown in total body calcium
turnover (Cann and Adachi, 1983). Adrenal glands were enlarged in
rats flown aboard Cosmos 782 (Morey and Baylink, 1978; Morey-Holton
et al., 1982) and it was suggested that increased glucocorticoid
levels may have contributed to the bone changes observed during
space flight. An extensive literature exists concerning the
effects of corticosteroids on calcium metabolism and bone changes
in man and in animal models. (For examples, see Bressot et al.,
1979; Clark and Roth, 1961; Clark et al., 1959; Hahn et al., 1979;
Jee et al., 1970; Klein et al., 1977; Lukert and Adams, 1976;
Simmons et al., 1979; and Yasumura et al., 1976).
Breaking strength determined by torsion loading was reduced
in femurs of rats flown aboard Cosmos 936; however, the defect was
corrected by the end of the 25-day postflight observation period
(Spengler et al., 1979). Femurs of rats maintained in a l-g cen-
trifuge during the Cosmos 936 flight did not display the adverse
effects noted in bones of rats subjected to weightlessness during
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flight. Results of tests of bone strength in vertebrae of rats
flown aboard Cosmos 1129 also suggested loss of bone strength
(Kazarian et al., 1980).
Studies of bone changes in rats during the 18.5 day
Cosmos 1129 flight confirmed and extended the findings of the pre-
vious studies. Periosteal bone formation was decreased in the
tibial and humeral diaphyses in proportion to their weight-bearing
function, while endosteal bone resorption was not measurably
changed (Wronski and Morey, 1983). In trabecular bone (proximal
tibial and humeral metaphyses) the mass of mineralized tissue was
decreased and the fat content of the bone marrow increased. The
osteoblast population was reduced near the growth cartilage-meta-
physeal junction, suggesting inhibition of bone formation during
space flight. Osteoclast numbers were not changed in the flight
animals (Jee et al., 1983). These histologic changes are similar
to bone responses in rats or rabbits following administration of
corticosteroids (Hulth and Olerud, 1963; Jee et al., 1966; Wang
et al., 1977) and those resulting from disuse (Wronski and Morey,
1983). Except for the trabecular bone mass of the proximal tibia,
the metaphyseal tissue returned to normal within 29 days postflight(Jee et al., 1983).
Lumbar vertebrae of the rats flown aboard Cosmos 1129
showed a decrease in calcium content of trabecular and cortical
bone at 6 days postflight. This change was not present immediately
postflight or at 29 days postflight and, in combination with post-
flight changes in keratosulfate in trabecular bone and chondroitin
sulfate in vertebral bone, indicated a possible slowing of bone
turnover during space flight, resulting in accumulation of older
bone (Eurell and Kazarian, 1983). They suggested that the older
bone was degraded by osteolysis immediately postflight, an inter-
pretation supported by an earlier observation of perilacunar osteo-
lysis in the metaphyses of long bones of rats 2 days postflight
(Yagodovsky et al., 1976). In both instances, replacement of bone
mineral content occurred by 27 to 29 days postflight.
In contrast, sections of rat mandible covered by masti-
catory muscle did not incur the decreased periosteal bone forma-
tion noted in weight-bearing bones. Additionally, growth and
maturation of the mandibular incisor seemed to be maintained
during space flight (Simmons et al., 1980). However, sections of
the jaw that had no contiguous muscle exhibited evidence of impaired
bone formation-calcification rates. A similar finding was reported
for tibial diaphysis of rats flown aboard the Cosmos biosatellites;
Spector et al. (1983) concluded that cessation of bone formation
did not occur where intrinsic muscle forces continued to act on
the tibia. Gravity density fractionation studies and ultrastruc-
rural studies of rat alveolar bone suggested delayed maturation of
bone mineral and matrix and differences in metabolic activities of
osteoblasts and osteoclasts. Recovery was complete at 19 days
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postflight (Simmons, 1981; Simmons et al., 1983). Suppression of
osteoblast differentiation was suggested by a change in relative
distribution of large to small nuclei in periodontal ligament
adjacent to alveolar bone (Roberts et al., 1981).
Based on the results observed in rats flown aboard the
Cosmos flights, further studies of changes in calcium homeostasis
are scheduled for an upcoming Spacelab flight (See Appendix B).
Quantitative histomorphometric analyses are planned to define more
specifically the time course of inhibition of bone formation and
differences in regional bone turnover at several skeletal sites in
juvenile and adult rats. In addition, metabolic studies will examine
changes in intestinal calcium absorption, routes of excretion, and
total skeletal turnover.
2. Ground-based studies
In ground-based studies weightlessness has been
simulated in the rat by suspending the animal in a harness made
of orthopedic casting material, thereby removing weight from the
hindlimbs and the lower vertebrae while allowing the forelimbs to
be normally weighted (Morey, 1979). Comparison of the effects of
this head-down suspension and space flight on the skeletal system
showed similar reductions in periosteal bone formation at the
tibiofibular junction, in trabecular bone volume, and in osteo-
blast populations. The osteoclast population was increased in the
head-down suspension model but not changed in the space flight ani-
mals (Morey et al., 1979; Morey-Holton and Wronski, 1981). Rats
suspended for 15 days absorbed calcium normally but showed progres-
sive loss of bone mass and mineral in unweighted bones only (Bikle
et al., 1982). Such differential bone loss may indicate that local
rather than systemic factors mediated the bone loss, a finding sup-
ported by lack of inhibition of periosteal bone formation by corti-
costerone administration to nonrestrained cold-stressed rats
(Morey-Holton et al., 1982).
In the suspended rat model 45Ca uptake by vertebrae and
tibia was depressed initially, but returned to control levels at
i0 days, and then rose to levels significantly greater than those
of control animals after 15 days of suspension (Doty and Morey-
Holton, 1982). The investigators concluded from these data that
bone resorption must be increased. However, electron photomicro-
graphs of osteoblasts from femurs of rats suspended for 14 days
showed a reduced number of gap junctions between cells in the peri-
osteum and endosteum, suggesting reduced activity of bone-forming
cells (Doty and Morey-Holton, 1982).
Histomorphometric bone changes have also been studied
during chair-restraint of Macaca nemestrina or full-body casting
of M. mulatta. In M. nemestrina restrained for as long as
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6 months, loss of cancellous bone from the axial skeleton (verte-
brae) was significantly greater than loss of cortical bone from
three appendicular sites (tibia, radius, and ulna) (Cannet al.,
1980). No losses were reported in radius and ulna, while loss in
tibia varied regionally. In the proximal tibia, trabecular and
cortical thinning was evident, while cortical striations were
apparent in the tibial midshaft. Serial measurements (computed
tomography or photon absorptiometry) indicated that vertebral
mineral loss did not level off as soon as mineral loss in peripheral
bone. In addition, the decrease in vertebral mineral content was
more closely related to negative calcium balance than was mineral
loss from peripheral sites, suggesting that the axial skeleton may
be more adversely affected than the appendicular skeleton by
extended immobilization (Cann et al., 1980). Electron probe
analysis showed decreases of approximately 25_ in calcium and
phosphorus content of cortical bone (Bunch et al., 1982).
Further study of loss of cortical bone mass in the proxi-
mal tibia during 6 months of restraint indicated that resorption
cavities were present within 1 month and large subperiosteal,
endosteal, and intracortical resorption cavities were apparent
after i0 weeks of restraint; that losses were localized predomi-
nantly in the proximal tibia with cortical thinning and endosteal
widening; and that bone mineral content in a cross section of tibia
decreased by 17 to 21% (Young and Schneider, 1981; Young et al.,
1983). In addition, bending stiffness of the tibia was decreased
by as much as 40_ during restraint. Normal bending properties
were restored after about 8.5 months of recovery. However, mineral
content of the proximal tibia was not restored in all cases after
15 months of recovery, at which time the cortex was comprised
mainly of first generation haversian systems. After 40 months of
recovery, normal properties of this compact bone appeared to be
restored (Young et al., 1983). Information presented at the ad hoc
Working Group meeting indicated that use of electromagnetic coils
for muscle stimulation, a technique reported successful for preven-
tion of bone rarefaction in rodents (Geiser and Trueta, 1958) had
been ineffective as a countermeasure in the restrained monkey and
that compressive loading on the tibia to simulate walking showed a
positive effect about 50_ of the time.
Striking changes were observed in an integrated series of
studies of metabolic, endocrine, and histomorphometric alterations
of calcium metabolism and bone in rhesus monkeys immobilized in
full-body casts in an .upright position for 14 days (Cann and Arnaud,
1981; Kazarian and Collins, 1981; Mathews et al., 1981; Russell and
Simmons, 1981; Simmons and Walker, 1981). Bone strength, energy
to ultimate load (the capacity of a specimen to absorb or store
energy), and bone stiffness of vertebrae were decreased at the end
of the casting period, but all showed a further decrease following
a recovery period of 14 days (Kazarian and Collins, 1981; Kazarian
and yon Gierke, 1981).
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Study of the histomorphometry of trabecular bone of verte-
brae indicated that bone formation surface decreased from 24_ of
total surface in control animals to 3_ in immobilized monkeys
(Mathews et al., 1981). Osteoblasts were absent and osteoid surface
was greatly reduced; however, mineralization continued. During
the recovery period, the bone formation surface increased to 13_.
Bone resorption surface was increased dramatically, from about 28_
for control animals to 46_ for the immobilized monkeys. At the end
of the recovery period the resorption surface remained elevated at
36_. The area of bone surface covered by osteoclasts showed a
200 to 300_ increase during casting and returned to normal levels
by the end of the 14-day recovery period. Cortical bone formation
in the ulna virtually stopped during the casting period and resumed
during recovery, while resorption spaces did not differ between
the control and immobilized monkeys (Mathews et al., 1981). The
changes observed in vertebrae and ulna of these monkeys were similar
to those in rats flown aboard Cosmos biosatellites. Small changes
in bone growth and maturation of mandibular bone were reported
(Russell andSimmons, 1981; Simmons and Walker, 1981); however,
these changes were different from those in mandibles of rats flown
in space.
In a preliminary report of analysis of serum biochemical
parameters in the immobilized rhesus monkeys, Cann and Arnaud
(1981) reported that total serum calcium decreased progressively
throughout immobilization. During the recovery period a large
transient increase in serum calcium occurred. Measures of 25-
hydroxycholecalciferol and PTH in some of the animals provided
tentative evidence for changes in concentrations of these hormones
related to changes in serum calcium concentration (Cann and Arnaud,
1981).
E. COUNTERMEASURES
Approaches to prevent the calcium losses observed during
space flight have focused on dietary mo;difications, physical tech-
niques, and pharmacological intervention. See Whedon (1981) for a
discussion of the influence of physical activity and nutrition on
maintenance of bone mass.
Dietary modifications first included supplemental oral
phosphate (1.3 g/d as the potassium salt). In human subjects the
supplemental phosphorus ingestion prevented the hypercalciuria of
bed rest but failed to prevent negative calcium balance or loss of
os calcis mineral (Hulley et al., 1971). Administration of cal-
cium and phosphate supplements (1.8 g calcium as calcium lactate
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and 3.0 g phosphorus) tended to reduce the hypercalciuria and uri-
nary excretion of hydroxyproline. During the first 12 weeks of
bed rest calcium balance was significantly less negative than that
of untreated control subjects, but after 12 weeks, mean calcium
balance fell to -i00 mg/d (Hantman et al., 1973).
Responses to other dietary modifications have also been
examined. Fluoride supplements (I0 mg F/d) improved calcium
balance in healthy ambulatory subjects; however, the supplement of
i0 mg F/d did not prevent calcium losses during bed rest (Maheshwari
et al., 1981; 1982). Urinary calcium excretion and calcium balance
also varied with protein intakes of 69, 102, and 156 g/d in five
ambulatory males. Mean daily protein intakes for astronauts in
the Apollo flights ranged from 51 g to 112 g (Rambaut et al.,
1975b), while the mean protein intake of the Commander of Skylab 3
was 85 g/d (Whedon et al., 1977). Increasing the protein intake
of the five ambulatory subjects to 156 g/d increased urinary cal-
cium losses, while decreasing the protein intake to 69 g/d lowered
urinary calcium excretion, resulting in slightly more positive cal-
cium balance. Fractional renal tubular reabsorption of calcium
was increased in subjects consuming the diet containing 69 g pro-
tein and decreased in subjects consuming the diet containing 156 g
protein (Schneider et al., 1981b).
Exercise regimens have been associated with slower bone
loss in patients with osteoporosis (Aloia et al., 1978; Kr_Iner
et al., 1983) and with increased bone density in athletes (Nilsson
and Westlin, 1971). Exercise plans employing a bicycle ergometer,
a Cybex Isokinetic Dynamometer, or a treadmill, were included in
the Skylab flights (Thornton and Rummel, 1977). While exercise
was not generally associated with decreased urinary calcium loss,
Whittle (1979) suggested that performance of "toe springs" on the
treadmill may have prevented loss of bone mineral from the os calcis
in one of the Skylab 4 crewmen. In U.S.S.R. space flights, 1.3 to
2.5 hours of exercise (warm-up exercises, rowing and bungee cord
exercises, and treadmill running and bicycling) are provided for
the cosmonauts. In some flights these protocols have b_en associ-
ated with decreased calcium losses and it has been stated that
changes in bone can be associated with changes in contractile prop-
erties of corresponding muscles (Gazenko et al., 1981; Oganov,
1981b).
Various levels of weight-bearing and/or exercise have
been tested in order to determine the amount of physical stress on
the skeleton required to prevent calcium loss during bed rest. In
subjects at bed rest, mineral loss from the os calcis and hypercal-
ciuria persisted during vigorous exercise regimens in the supine
position (Hulley et al., 1971; Issekutz et al., 1966). Lower body
negative pressure and static and intermittent longitudinal compres-
sion in the supine position were also ineffective in improving cal-
cium balance (Hantman et al., 1971; Hulley et al., 1970). Use of
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a reverse gradient garment to induce venous pooling during bed
rest was associated with a greater increase in urinary calcium
excretion than bed rest alone (Sandler et al., 1983).
Quiet standing produced less clear results. Issekutz
et al. (1966) reported that urinary calcium levels fell slowly to
the basal level with 3 h/d of quiet standing with the remainder of
the day in bed, but a report of Schneider et al. (1981c) indicated
that neither calcaneal mineral density nor calcium balance was pro-
tected by this regimen. No further improvement was noted with 20
or 40 minutes of upright exercise on a bicycle ergometer (Issekutz
et al., 1966; Schneider et al., 1981c). Impact loading (loads of
25 or 40 pounds to each heel and compression of 80_ of body weight
to the axial skeleton for 6 or 8 h/d) to create a piezo-electric
stimulus did not affect overall calcium loss but did maintain or
increase calcaneal mineral density (Schneider et al., 1981d,e). A
second type of impact loading procedure (repetitive brisk dropping
of the erect body weight from a "tiptoe" position to the heel pads
once per second for 15 minutes four times daily) was associated
with improved calcium balance (Schneider et al., 1981b).
The increased urinary excretion of calcium was reduced by
about 50_ by use of a bed oscillating through an arc of 25 ° once
every 2 minutes for 8 hours, a technique that partly reproduces /
the effect of weight bearing (Whedon et al., 1949). Three hours
of random ambulation daily resulted in less negative calcium bal-
ance for subjects otherwise at bed rest; however, 4 hours of con-
trolled ambulation daily on a measured course during 6 weeks of
bed rest (20 h/d) was considered necessary to completely alleviate
negative calcium balance (Schneider et al., 1981c). These results
indicate that both exercise and weight bearing are necessary to
counteract the bone mineral loss that occurs during prolonged bed
rest.
Administration of pharmacological doses of synthetic
salmon calcitonin (I00 Medical Research Council Units/d intra-
muscularly) did not prevent negative calcium and phosphorus balances
during bed rest (Hantman et al., 1973). However, a combination of
synthetic salmon calcitonin, longitudinal compression, and supple-
mentary calcium and phosphate administered to two subjects during
8 weeks of bed rest resulted in maintenance of calcium balance and
a smaller increase in hydroxyproline excretion in both subjects,
and prevention of calcaneal mineral loss in one of the two subjects
(Hantman et al., 1973).
Effects of two disphosphonate compounds, EHDP (disodium
ethane-l-hydroxy-l,l-diphosphonate) and clodronate (disodium di-
chloromethylene diphosphonate), on calcium metabolism have been
investigated during bed rest. Diphosphonates are synthetic com-
pounds structurally related to pyrophosphate and have been shown
to inhibit both soft tissue calcification and bone resorption in
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several in vitro and in vivo systems (Fleischet al., 1969;
Francis et al., 1969; Martodam et al., 1983). EHDP is thought to
act on two aspects of bone metabolism: to reduce the rate of bone
resorption and inhibit bone mineralization. At a dose of 20 mg
EHDP/kg/d, calcium and phosphorus balances improved only during
the last 8 weeks of a 20-week study involving four healthy men at
bed rest. Urinary hydroxyproline excretion and calcaneal mineral
losses decreased during the final 3 weeks of the study. However,
this dose level was subsequently associated with development of
osteomalacia (Bone et al., 1979). A lower dose of EHDP (5 mg/kg/d)
had no effect (Lockwood et al., 1975).
Clodronate treatment was a more effective means of
decreasing the hypercalciuria observed during bed rest (Schneider,
1981; Schneider and McDonald, 1981). During a 6-week ambulatory
preloading period, nine subjects received 1.6 g/d of clodronate
while five control subjects received a placebo. During the ambula-
tory preloading period both urinary calcium and urinary hydroxy-
proline dropped significantly in the clodronate-treated group but
not in the control group. Filtered urinary calcium, renal calcium
reabsorption, and serum concentrations of total and ionized cal-
cium did not change in the clodronate-treated group. During the
17-week period of bed rest, hypercalciuria was absent in the
clodronate-treated subjects and calcium and phosphorus balances
were significantly less negative than in the control group. Seven
of the nine subjects receiving clodronate exhibited no loss of cal-
caneal density while only two of the five placebo-treated subjects
maintained calcaneal mineral content during bed rest (Schneider,
1981; Schneider and McDonald, 1981). However, subsequent identi-
fication of serious side effects in patients receiving clodronate
have contraindicated further use of this drug (Bounameaux et al.,
1983).
Material presented at the ad hoc Working Group meeting
reported that administration of acetazolamide, a carbonic anhydrase
inhibitor, did not inhibit bone loss in rats. Use of carbonic
anhydrase inhibitors has been associated with increased formation
of renal stones (Parfitt, 1969).
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IV. THE NASA BIOMEDICAL RESEARCH PROGRAM
IN BONE DEMINERALIZATION
The NASA Biomedical Research Program in bone deminerali-
zation is conducted through in-house research efforts at Ames
Research Center, Johnson Space Center, and the Jet Propulsion
Laboratory, and through grants to university scientists. The bone
demineralization research presently conducted at the three space
centers and the universities is ground-based. Work at the Ames
Research Center has centered on development of restrained monkeys
(M. nemestrina) and suspended rats as ground-based models for
analysis of bone alterations during weightlessness. Work at the
Johnson Space Center has focused on biochemical and endocrine
factors associated with bone loss during weightlessness and devel-
opment "of effective countermeasures. The human bed-rest research
program on bone demineralization now located at the University of
Texas is associated with the research program at Johnson Space
Center. Projects housed at the Jet Propulsion Laboratory are
related to development of noninvasive measures of bone loss. In
addition to these ground-based efforts, several experiments per-
taining to bone demineralization are scheduled for upcoming Space-
lab flights. See Appendix A for summaries of the 16 in-house and
extramural projects relating to bone demineralization supported by
the NASA Biomedical Research Program in Fiscal Year 1983, and
Appendix B for summaries of inflight experiments planned for
Spacelab missions.
The LSRO ad hoc Working Group concluded that, in general,
the research projects in bone demineralization sponsored by the
NASA Biomedical Research Program fall within the guidelines for
areas of research recommended in the reports of the Space Science
Board Committee on Space Biology and Medicine (Bricker, 1979) and
the NASA Life Sciences Advisory Committee Report of 1978 (Whedon,
1978). The total program is periodically reexamined and reviewed
in response to revisions in scientific guidance and research pri-
orities, addition of new research tasks, and deletion of completed
projects or efforts of decreased importance. In contrast to the
recommendations of one of the earlier Committees which emphasized
the endocrine approach for the study of bone loss during space
flight (Bricker, 1979), the LSRO ad hoc Working Group considered
the study of the pathogenesis of bone changes in man and validated
animal models of primary importance to NASA's research program in
bone demineralization. The propensity for formation of renal
stones during space flight should also be examined and these
studies coordinated with studies of bone loss.
The LSRO ad hoc Working Group concluded that the NASA Bio-
medical Research Program includes areas of research important for
study of bone demineralization during space flight. However, they
agreed that the program needs improved definition of short- and
long-term objectives. While cognizant that their opinions were
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based in part on abstracted information that might not completely
represent all aspects of each project to NASA's mission-oriented
research needs, the Working Group recommended that projects be
more clearly focused to meet NASA's research objectives. A strong
in-house and extramural ground-based program closely coordinated
with inflight experiments was considered critical for documenta-
tion of bone change and prediction of its consequences and for
development of countermeasures to prevent or minimize these losses.
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V. OBSERVATIONS OF THE AD HOC WORKING GROUP
ON BONE DEMINERALIZATION
The observations of the ad hoc Working Group centered upon
the following topics: (i) pathogenesis of bone demineralization,
(2) potential for occurrence of renal stones consequent to pro-
longed hypercalciuria, (3) development of appropriate ground-based
and inflight models to study bone demineralization, (4) integra-
tion of research efforts, and (5) development of effective counter-
measures. These discussions and suggestions for further research
in bone demineralization will aid NASA in planning research programs
and stimulate investigators to initiate research directed toward
resolution of the problems of bone demineralization during space
flight_
A. PATHOGENESIS
I. Assessment
Bone loss during space flight is poorly understood
in terms of the processes underlying bone alteration. It was the
opinion of the Working Group that the mechanisms are undoubtedly
complex and their elucidation will require much more effort. Loss
of bone mineral during space flight is indicated by metabolic
studies showing negative calcium and phosphorus balances and by
noninvasive measures of bone density changes. Such findings indi-
cate a net difference between anabolic and catabolic processes,
but provide little information concerning the mechanisms involved
under conditions of weightlessness.
Knowledge of the mechanisms of changes in rat bone has
been obtained during space flight. As detailed in Section III-D
(p. 16), data from rats flown aboard the Cosmos biosatellites
indicate that bone formation rates are decreased, but that bone
resorption rate is not affected by space flight, suggesting a
slowed bone turnover during space flight (Cann and Adachi, 1983;
Eurell and Kazarian, 1983; Jee et al., 1983; Wronski and Morey,
1983). Although the bones of rats exhibit continued growth in
contrast to the remodeling system of many other species, including
man, examination of histomorphometric changes in bones of rats
flown aboard the Cosmos biosatellites showed alterations quite
similar to those described for bones of monkeys (M. mulatta)
immobilized for 14 days (See Section III-D, p. 16).
Studies of histomorphometric changes in bone done in two
species of monkeys (M. nemestrina and M. mulatta) were considered
by the Working Group as not directly c_mparable to each other
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because of differences in techniques of immobilization, differ-
ences in lengths of restraint, and differences in behavioral re-
sponse to immobilization. It remains to be established whether
changes during space flight will be similar to changes observed in
ground-based experiments in either of these models. Their relevance
for study of bone changes in humans also remains to be determined.
Knowledge of primary changes in bone of normal human sub-
jects during bed rest is lacking and the ad hoc Working Group was
aware of only one study of quantitative histomorphometry of para-
lyzed patients (Minaire et al., 1974). The Working Group emphasized
that study of bone changes in human subjects during simulated as
well as actual weightlessness is essential to gain an understanding
of the pathogenesis of bone loss during space flight. Understanding
of the mechanisms of bone loss during space flight in human subjects
and in an animal model having a bone-remodeling system similar to
that of man was considered a most important research goal for the
NASA Biomedical Research Program. Knowledge of the types of changes
occurring in bone in man is essential for validating any model of
immobilization bone loss, for predicting reversibility and conse-
quences of immobilization bone loss, and for developing effective
countermeasures.
2. Research suggestions
The effects of real and simulated weightlessness on
alterations in bone histomorphometry should be investigated in hu-
man subjects and relevant animal models. Quantitative histomorpho-
metric analyses to indicate rates of bone formation and bone sur-
faces involved in resorption should be conducted in normal human
volunteers during bed rest and, if possible, during exposure to
weightlessness of space flights. If indicated by results of quan-
titative histomorphometric analyses, studies of bone cultures
exposed to weightlessness might subsequently provide a means of
identifying specific aberrations in bone cell metabolism.
Types of bone preferentially mobilized should be deter-
mined. The site(s) releasing calcium from bone should be identi-
fied, i.e., trabecular or cortical bone and specific sites within
these types of bone. In addition, the organic matrix should be
examined for changes to determine whether existing collagen is
undergoing physical change or if osteoblast function is altered,
resulting in synthesis of faulty collagen. It was suggested that
measurement of urinary excretion of peptides containing hydroxypro-
line (Krane et al., 1977) or of serum bone GLA protein, (Delmas
et al., 1983; Patterson-Allen et al., 1982; Price et al., 1982)
might provide a better index of bone remodeling than the total
urinary hydroxyproline excretion measurements. Monitoring of the
progression of such changes is important in terms of detecting
early, subtle, subclinical changes and determining the reversibility
of the bone loss.
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Exposure to weightlessness may also affect local events
in the bone microenvironment of primary importance to skeletal
maintenance (Urist et al., 1983). Removal of physical-mechanical
stress and changes in muscle action may result in alterations of
piezo-electric forces and local factors such as osteoclast acti-
vating factor, prostaglandins, and growth factors influencing bone
cell function. Circulatory changes and fluid shifts occurring
during exposure to weightlessness (Nicogossian and Parker, 1982;
Thornton and Hoffler, 1977; Thornton et al., 1977) may also affect
bone cell metabolism in a localized fashion (Geiser and Trueta,
1958; Heaney, 1962). It was the opinion of the ad hoc Working
Group that the role of such factors must be considered more
extensively in future research efforts.
B. ENDOCRINE EFFECTS
I. Assessment
Direct roles of hormones (PTH, 1,25-dihydroxychole-
calciferol, and calcitonin) in bone metabolism have long been
recognized and mechanisms of these hormones in bone formation and
resorption have been the subject of extensive research efforts.
The studies of plasma levels of PTH, 25-hydroxycholecalciferol,
and calcitonin in Skylab astronauts during space flight did not
indicate consistent changes of a magnitude that would ordinarily
be associated with increased mobilization of bone (Leach and
Rambaut, 1977) and general systemic effects cannot explain the
local and preferential demineralization of weight-bearing bones.
However, the ad hoc Working Group did not dismiss possible effects
of PTH, 1,25-dihydroxycholecalciferol, or calcitonin on bone mobi-
lization during space flight. At the time the hormone levels were
measured during previous space flights, assays for a number of hor-
mones were not well refined and it is difficult to draw conclusions
from those data.
In light of the findings of decreased plasma levels of
1,25-dihydroxycholecalciferol in immobilized patients (Stewart
et al., 1982), analyses of vitamin D metabolites planned for the
Spacelab 2 astronauts may provide information concerning the changes
in calcium metabolism during space flight. However, the opinion
of the Working Group was divided over the value of information
obtained by analysis of vitamin D alone.
Development of improved techniques for quantitation of
PTH (intact, N-terminal, and C-terminal) (Goltzman et al., 1980;
Kao et al., 1982; Parthemore et al., 1978; Roos and Deftos, 1979;
Roos et al. 1981; Slovik et al., 1980) may provide a more accu-
rate indication of changes of levels of this hormone during space
flights. Since physiologic responses during weightlessness differ
29
from those under gravity, it may be possible that responses of
bone cells to normal levels of hormonal agents in weightlessness
differ from responses on the ground. This may be particularly
evident in bones that lack their normal stimuli.
Observations of unpublished radiographic data on changes
in bones of restrained monkeys presented at the ad hoc meeting
suggested to some members of the Working Group that the changes
were similar to those associated with hyperparathyroidism, senile
osteoporosis, and renal osteodystrophy. They concluded that deter-
mination of changes in bone was necessary to indicate future direc-
tions for study of hormonal changes and that further research at
the present time to find a role for calcitropic hormones in bone
demineralization during space flight should be coordinated with
direct study of bone histomorphometry.
The Working Group considered possible effects of other
hormones influencing bone metabolism. Urinary excretion of corti-
sol in astronauts was elevated during space flight (Leach and
Rambaut, 1977) and adrenal glands of rats flown aboard the Cosmos
782 biosatellite were enlarged (Morey and Baylink, 1978). It was
the opinion of the Working Group that an elevation in cortisol se-
cretion may be an accessory factor in bone demineralization during
exposure to weightlessness. However, it did not seem likely to
most members of the Working Group that cortisol is the sole stimu-
lus for the increased bone mobilization observed during space
flight. This opinion was based on observations that urinary cor-
tisol excretion was not increased in subjects during bed-rest
studies _LaRochelle et al., 1982), yet urinary calcium excretion
is still elevated to a similar extent during bed rest as during
space flight (Donaldson et al., 1970; Hulley et al., 1971). Roles
of other endocrine agents such as thyroid hormone, aldosterone,
and prolactin were considered peripheral to the problem of bone
demineralization during space flight.
2. Research suggestions
Although the ad hoc Working Group recognized the
extremely important influence of the endocrine system on bone,
they considered that changes in circulating levels of hormones
which regulate calcium metabolism probably were not a primary
stimulus for changes in bone metabolism during space flight. They
suggested further study of hormonal influences in conjunction with
study of hypercalciuria and histomorphometric changes in bone of
astronauts and subjects at bed rest and in appropriate animal models
(See Sections III-D, p. 16; V-C, p. 31; and V-D, p. 33). PTH and
cortisol were the endocrine factors noted most likely to influence
skeletal calcium mobilization under conditions of real and simu-
lated weightlessness. Quantitative determinations of the cir-
culating levels of PTH and of 24-hour urinary excretion of free
cortisol were considered the most sensitive estimates of changes
in levels of these hormones.
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C. MODELS
i. Assessment
Several models have been used for evaluation of bone
demineralization during real or simulated exposure to weightless-
ness. None has been completely validated and it is possible that
the models do not correlate very well with each other or with the
changes occurring in humans in space. During actual space flight
and its ground-based analog of bed rest, changes in calcium bal-
ance, and bone density have been measured in man. No histological
information has been published on human bone during space flight
or on an animal model having a bone remodeling system similar to
that of man.
Changes in bone of rats flown in space have been compared
to some extent to a ground-based immobilized rat model and found
similar (Morey, 1979). Some bone changes in the rats flown in
space are also similar to bone changes in ground-based immobilized
monkeys (Mathews et al., 1981). The Working Group recognized that
the separation of bone formation and bone resorption sites in rat
bone afforded an opportunity to study each process independently.
However, differences in the steady-state relationship of 45Ca
between bone and blood in growing rats and dogs suggest a signifi-
cant difference in skeletal dynamics for the two species (Klein,
1981). A majority of members questioned the appropriateness of
the continually growing rat bone as a model for the bone remodeling
system of human adults, but the opinion was also expressed that
study of selected aspects of bone metabolism in rats would provide
valuable information concerning bone loss during space flight.
For example, trabecular bone in the tail vertebrae of rats is
remodeled in a manner somewhat similar to that of adult human
iliac crest (Vignery and Baron, 1980). It may be appropriate to
examine changes in the histomorphometry of the trabecular spongiosa
of this bone source.
Nonhuman primates, M. nemestrina and M. mulatta, have
also been used as models in ground-based studies of bone loss
during immobilization. The ad hoc Working Group concluded that
there are insufficient comparative data to indicate whether the
changes occurring during immobilization are similar for the two
species or whether the changes observed in ground-based studies
are the same as the changes that may occur during space flight in
either species. Because the bone remodeling system in nonhuman
primates may be similar to that of the human, the Working Group
suggested their continued use as models.
Based on consideration of the strengths and weaknesses of
the above mentioned animal models, the ad hoc Working Group con-
cluded that it has not been determined that any of the models used
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thus far is completely adequate for the investigation of human
bone loss during weightlessness. The Working Group considered it
essential to know that the bone changes in a particular model
approximate changes in human bone during space flight. They recom-
mended that an animal model be systematically deve!oped in a
ground-based situation with assurances that the changes occurring
in space flight are the same as those occurring in the ground-
based counterpart and in man. Mature monkeys, dogs, and miniature
pigs were named as the species that have bone-remodeling systems
similar to that of man.
After reviewing the ground-based studies of calcium loss
in the human bed-rest experiments and the various animal models,
the ad hoc Working Group considered that human volunteers at bed
rest probably provide the best ground-based model for study of
effects of weightlessness on bone changes of astronauts. Calcium
balance and bone mineral loss from os calcis are similar in ground-
based subjects during bed rest and in astronauts. However, histo-
morphometric evidence that changes in bone are similar is lacking.
Comparisons of hormonal profiles during, bed rest and space flight
are incomplete but do indicate that levels of cortisol in subjects
at bed rest do not increase (LaRochelle et al., 1982), whereas uri-
nary excretion of cortisol was markedly increased in astronauts
(Leach and Rambaut, 1977). The Working Group emphasized that while
the stffdy of astronauts inflight and human subjects at bed rest is
essential, there is little chance of finding an answer to the prob-
lem of bone demineralization using studies in man alone because of
the inherent nature of experimentation with human subjects.
Mathematical models may have heuristic value for contrib-
uting to the understanding of bone demineralization during space
flight. Several models have been proposed (Brand, 1983; Leonard
et al., 1979; White et al., 1982). The Working Group cautioned
against premature use of mathematical models and stressed the
importance of generating valid physiological data with bone as the
central component for mathematical models.
2. Research suggestions
The ad hoc Working Group recommended development
and validation of a ground-based model of bone demineralization
that shows biochemical, hormonal, and histomorphometric changes
that correspond to the changes occurring in that species and in
man during space flight. Observation of histomorphometric change
of bone in astronauts is essential to this effort to provide a
benchmark for comparison and validation of any ground-based or
space-flown model. Mature monkeys, dogs, and miniature swine were
suggested as animal models having bone remodeling systems similar
to that of man. However, the Working Group urged continued caution
in extrapolation of data from animal models to man.
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Expansion of the studies of human volunteers during bed
rest was recommended. These studies should include women and
should examine the problem of calcium metabolism, bone loss, and
hypercalciuria comprehensively, from histomorphometric, biochemical,
and endocrinologic aspects in order to maximize the information
obtained. Histomorphometric study of bone changes should be given
high priority and related to changes in bone as evaluated by nonin-
vasive methods and to changes in hormonal profiles. Rapid advances
in the development of programmed and fully automated instruments will
expedite the acquisition of quantitative histomorphometric data.
Studies of parameters associated with renal stone development should
be conducted in bed-rested subjects and in astronauts.
D. INTEGRATED RESEARCH APPROACHES
i. Assessment
The ad hoc Working Group observed that much of the
research on bone demineralization was performed and published in a
fragmented manner. Some information has been obtained using various
animal models (See Section III-D, p. 16); however, because the
models vary considerably from each other (for example, the behav-
ioral responses of the two species of immobilized monkeys and thus
probably their endocrine profiles), the Working Group questioned
whether information obtained using one model could be extrapolated
to other models or to man.
In addition to bone mineral loss from os calcis, muscle
deconditioning and loss of muscle mass has been observed, particu-
larly in the lower extremities (Thornton and Rummel, 1977; Whittle,
1979). Some effects of exercise on muscle mass and deconditioning
have been described (Leonard et al., 1983; Thornton and Rummel,
1977; Whittle, 1979). However the association between bone loss,
muscle loss and deconditioning, and exercise remains to be thor-
oughly examined. A parallel study by LSRO ("Research Opportuni-
ties in Muscle Atrophy," edited by G.J. Herbison and J.M. Talbot)
addresses the occurrence of muscle changes during space flight.
Renal stone formation is associated with hypercalciuria,
hyperuricosuria, and hypocitraturia (Coe and Favus, 1980; Nicar
et al., 1983; Pak, 1981) and with bed rest in convalescent patients
(Albright et al., 1941; Leadbetter and Engster, 1945; Tori and
Kewalramani, 1978). While there is evidence of hypercalciuria in
space flight, there are no reports of urolithiasis in those astro-
nauts participating in metabolic balance studies inflight. Thus,
the potential for renal stone formation remains a possibility.
Despite the absence of reports, evidence from inflight studies
suggests the occurrence of changes in urine composition that may
alter the propensity for renal stone formation. Decreases in
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plasma levels and excretion of uric acid suggest a possible altera-
tion in metabolism of that compound during space flight (Leach and
Rambaut, 1975). Because of potassium loss during space flight
(Leach and Rambaut, 1975), renal citrate excretion may be impaired
(Fourman and Robinson, 1953). Defective citrate excretion was
also suggested from studies of normal volunteers during bed rest
(Deitrick et al., 1948). Taken together, these observations
suggested to members of the Working Group that the tendency for
renal stone formation might be affected during space flight.
Useful information concerning the amount of bone mineral
lost durZng space flight and immobilization has been obtained with
photon absorptiometry and computed tomography techniques. Each of
the methods has specific advantages and limitations (Cohn, 1981;
Elsasser and Reeve, 1980; Genant et al., 1983; Mazess, 1983).
Immobilization and corticosteroid use have been associated with
preferential loss of trabecular bone (Hahn et al., 1974; Minaire
et al., 1974). A measurement that provides an indication of the
density of trabecular bone itself might prove useful in evaluating
bone loss induced by weightlessness; however, according to a recent
review (_azess, 1983), existing computed tomography and photon
absorptiometry techniques are not presently sensitive enough for
such measurements. The ad hoc Working Group considered it unlikely
that continued development and refinement of computed tomography
or photon absorptiometry would show either method preferable for
all uses. It was the opinion of the Working Group that continued
use should be made of these techniques as well as use of other non-
invasive methods of calcium measurement such as neutron activation.
2. Research suggestions
For those investigators whose research would lend
itself to a broader approach, NASA should encourage projects inte-
grating several areas possibly related to bone demineralization.
For example, some studies of bone loss could be expanded to include
evaluation of the tendency for renal stone formation and of other
changes in body composition, i.e., loss of muscle mass and electro-
lytes. Neutron activation analysis may be a useful technique for
studies of changes in body composition. It was also suggested
that coordinated research projects include quantitation of muscle
fiber changes from biopsy samples and measurement of glycogen con-
tent and activity of enzymes involved in aerobic and anaerobic
metabolism in muscle fibers in conjunction with comprehensive
studies of bone loss.
Biomedical studies in space flight should include as many
analyses as possible. Much more valuable information could be
obtained if plasma samples of crew members of Spacelab 2 were
analyzed for PTH, corticosteroids, and total and ionized calcium
in addition to the vitamin D metabolites. Analyses of plasma and
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urinary levels of corticosteroids in the crew members of Spacelab 4
would be a worthwhile addition to the more comprehensive metabolic
experiments planned for that flight. If compatible with other bio-
medical experiments utilizing nonhuman primates scheduled for
Spacelab 4, direct observation of quantitative histomorphometric
changes in bone of these animals could supply detailed information
concerning mechanisms of bone loss.
Development of newly emerging techniques for noninvasive
measures of skeletal status should be continued and application of
existing techniques should be expanded. While it is unlikely that
development of these techniques will provide new clues to the
etiology or pathogenesis of bone loss, they may be very useful for
testing various pharmacologic agents or other countermeasures used
to inhibit bone loss.
E. COUNTERMEASURES
I. Assessment
Attempts to prevent bone demineralization during
exposure to weightlessness have followed three approaches: manipu-
lation of the dietary intake of nutrients, application of physical
stress by various forms of exercise, and pharmacological interven-
tion. Some trials of countermeasures have been conducted during
space flight in astronauts and more extensively in ground-based
studies of human volunteers during bed rest and in an immobilized
monkey model (M. nemestrina).
Although fecal calcium excretion is increased during bed
rest and space flight, it has not been ascertained whether intesti-
nal calcium absorption is impaired. Calcium balance could not be
maintained for more than 3 months by administration of supplemental
calcium and phosphorus to human volunteers during bed rest (Hantmann
et al., 1973; Schneider, 1981). Based on this work, the ad hoc
Working Group agreed that dietary supplementmtion of calcium and
phosphorus was not an effective approach for preventing negative
calcium balance during space flight. The effect of calcium supple-
mentation alone with a dietary Ca:P ratio greater than I:i has not
been assessed. The ad hoc Working Group expressed concern that
the hypercalciuria was slightly aggravated and not alleviated by
the simultaneous addition of calcium and phosphorus, thereby
possibly enhancing the potential for formation of renal stones.
Because renal excretion of calcium varies directly with
the level of dietary protein intake (Altchuler, 1982; Schneider,
1981) the role of dietary protein in hypercalciuria requires fur-
ther study. The ad hoc Working Group suggested that reducing of
the dietary protein intake (and thereby probably decreasing the
acceptability of the diet) during space flight would not be a
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practical means of decreasing renal excretion of calcium. They
did state, however, that increase of dietary protein was not indi-
cated on the basis of nutritional needs and might be contraindi-
cated by a possible propensity for stone formation. A high protein
intake may contribute to renal stone formation by increasing uri-
nary excretion of uric acid and decreasing urinary excretion of
citrate (Robertson et al., 1979). In regard to the possibility of
increased renal stone formation during space flight, the ad hoc
Working Group recommended that high fluid intake of at least 3 I/d
be maintained throughout space flight as a possible means of
reducing this potential.
Although addition of optional exercise regimens to space
flight schedules did not completely prevent negative calcium bal-
ance or modify the hypercalciuria in astronauts, it has been
suggested that use of the treadmill may have moderated loss of
os calcis mineral in one instance (Whittle, 1979). See Section
III-E (p. 21) for information concerning exercise routines employed
during space flights and bed-rest studies. Walking a prescribed
course for 4 hours each day fully prevented the negative balance
in ground-based bed-rest studies (Schneider, 1981); and, as a pro-
tective measure in weightlessness, some forms of stress on the
skeleton equivalent to 4 hours of walking on Earth would have to
be devised.
Pharmacologic preparations to prevent loss of bone calcium
have been investigated in human volunteers at bed rest and in rats
(See Section III-E, p. 21). Based upon their review of the pharma-
cologic preparations tested, it was the opinion of the ad hoc
Working Group that diphosphonate compounds (EHDP and clodronate)
have shown the most promise as potential countermeasures. How-
ever, as recognized by NASA investigators, serious side effects of
clodronate and higher doses of EHDP recognized subsequent to the
bed-rest studies of these compounds, indicate that these particular
diphosphonates are unacceptable for further use. Again, the
Working Group stressed the importance of knowledge of the factors
primarily responsible for the bone loss during exposure to weight-
lessness in identification of a safe and effective countermeasure.
2. Research suggestions
Although plasma levels of 1,25-dihydroxycholecalciferol
are decreased in immobilized patients (Stewart et al., 1982), it
has not been established that intestinal absorption of calcium is
impaired in healthy subjects during bed rest (Lockwood et al., 1975).
Administration of supplemental calcium and phosphorus, though tem-
porarily maintaining calcium balance at close to zero, did not pre-
vent hypercalciuria during bed rest (Hantman et al., 1973). Because
of these findings and because of their concern over the effects of
prolonged hypercalciuria, the ad hoc Working Group was reluctant
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to recommend further extensive investigation of dietary intervention
as a countermeasure. However, one consultant suggested that dietary
supplementation of calcium alone be considered in any further studies
of dietary intervention.
The Working Group considered that study of the changes in
bone taking place during an effective exercise regimen (walking for
4 h/d) might provide insight into the mechanisms responsible for
changes occurring in bone metabolism during immobilization and
reambulation. Such studies may help to identify roles of such
factors as muscle pull, mechanical stress, piezo-electric forces,
and altered circulation on bone demineralization during actual or
simulated weightlessness. In view of effects of previous exercise
protocols on calcium loss in the United States and U.S.S.R. space
programs, the Working Group considered that exercises placing
stress on the weight-bearing bones equivalent in forces to 4 hours
of walking on Earth might prove efficacious. Other suggestions of
the members of the ad hoc Working Group included more vigorous use
of a bicycle ergometer, strenuous jogging or other exercise on a
treadmill, or lifting the lower limbs against varying fixed resis-
tance or loads such as those found on a Cybex machine. Use of a
Cybex machine, in particular, would allow exercise of individual
muscle groups such as the quadriceps and hamstring muscles, an
approach that might help to counteract calcium loss during space
flight.
Further research on pharmacologic preparations was sug-
gested as a feasible means of identifying an efficacious counter-
measure for bone demineralization. Human calcitonin, administered
at intermittent intervals to avoid the "escape phenomenon" was con-
sidered as a possible approach. Because administration of anabolic
steroids was shown to promote nitrogen balance and to have a pos-
sible slowing effect on progression of postmenopausal osteoporosis
(Chestnut et al., 1977) and disuse osteoporosis (Heaney, 1962),
one member of the ad hoc Working Group suggested consideration of
use of anabolic steroids as a countermeasure. Investigation of
doses of fluoride greater than the I0 mg F/d previously tested may
be indicated if studies of bone dynamics show that bone formation
is inhibited during exposure to weightlessness. Because two diphos-
phonate compounds (clodronate and EHDP) were partially effective
in reversing calcium loss during bed rest, a third diphosphonate
compound, amino propylidene diphosphonate (APD), was considered
the most appropriate pharmacologic agent for testing as a means of
alleviating bone loss during space fIight. Depending on results
of safety testing of this compound, the Working Group recommended
that studies of countermeasures next address the efficacy of APD
during bed rest.
37

VI. PRIORITIES FOR SUGGESTED RESEARCH
The discussions and deliberations of the ad hoc Working
Group led to the proposed priorities for suggested research listed
in Table I. The categories of research are interrelated and all
were regarded as important for future research consideration.
Within the separate categories the suggestions for research are
listed in decreasing order of priority.
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Table i. Suggested Priority for NASA Research in
Bone Demineralization*
A . PATHOGENES IS
e Distinguish processes causing primary changes in
bone during weightlessness from associated influences
such as changes in hormone levels that may result
from, rather than cause, changes in bone.
• Analyze and compare quantitative histomorphometry of
bones of human subjects exposed to real and simulated
weightlessness to determine the gravity-dependent
responses of bone itself.
o Study effects of real and simulated weightlessness
on histomorphometry of trabecular and cortical bone
from different sites (axial and appendicular) in an
appropriate animal model in inflight and ground-based
studies to determine the type of bone preferentially
mobilized.
• Examine collagen at bone sites most severely affected
by weightlessness to determine whether existing
collagen is modified or if newly-synthesized collagen
is defective.
o Continue to study changes in bone density resulting
from exposure to zero-gravity. Examine changes at
sites in addition to those previously observed to
assess change in a more comprehensive manner.
• Extend the length of follow-up studies of bone loss
in astronauts and subjects at bed rest to determine
if effects of real and simulated weightlessness on
bone demineralization are reversible.
• Determine the results of weightlessness on local bone
mechanisms: e.g., effects of removal of physical-
mechanical stress and piezo-electric stimuli on bone,
changes in influences of muscle action on bone, and
consequences of altered circulation induced by
weightlessness on bone cell metabolism.
• Examine bone cell metabolism by tissue culture
techniques to extend the definition of changes
occurring during space flight.
* Listed in suggested decreasing order of priority within each
of four separate categories. See Section V, A-D for detail.
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B. ENDOCRINE EFFECTS
• Determine endocrine changes simultaneously with bone
changes in human subjects and appropriate animal
models.
o Determine and compare effects of weightlessness on
plasma concentrations and urinary excretion of
hormones in astronauts and subjects during bed rest.
o Analyze plasma and urine samples from subjects of
ground-based experiments to determine if there is a
substance that correlates to loss of bone mineral
and could serve as a marker of bone demineralization.
C. _ODELS
o Study bone histomorphometry and associated bio-
chemical and endocrine changes of astronauts during
space flight to establish a basis for development
and validation of a ground-based and space-flown
animal model to evaluate bone demineralization,
potential for formation of renal stones, and effi-
cacy of countermeasures.
o Expand the studies of subjects during bed rest.
Compare the bone changes and biochemical and
hormonal alterations in astronauts with those of
healthy male and female subjects during bed rest.
o Dev@lop and validate a ground-based animal model
exhibiting histomorphometric, biochemical, and
hormonal changes that correspond to the changes
observed in that species and in man during space
flight.
o Develop mathematical models for bone loss based
upon observations of changes in bone during space
flight in man and in validated animal models.
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D. INTEGRATED RESEARCH APPROACHES
o Examine the problem of bone demineralization from
histomorphometric, endocrine, and biochemical aspects
simultaneously. Integrate study of the potential
for renal stone formation into these studies.
Correlate bone loss during space flight and bed
rest with loss of muscle mass and electrolyes.
o Maximize the amount of information obtained from in-
flight experiments. Two suggestions for accomplishing
this were increasing the number of analyses of blood
and urine samples collected inflight as well as pre-
and postflight and, whenever possible, combining
studies of bone loss with studies of other physio-
logical changes during space flight.
o Continue to develop and refine newly emerging tech-
niques for noninvasive measures of skeletal status.
Expand application of these techniques for evaluation
of bone loss.
E. COUNTERMEASURES
o Evaluate the effect of amino propylidene diphospho-
nate (APD) on bone loss and hypercalciuria during
bed rest if safety tests of the drug prove satis-
factory. Other drugs that might be considered for
testing are fluoride (in larger doses than previously
tested), human calcitonin administered on an inter-
mittent schedule, and anabolic steroids.
o Assess in a ground-based program the changes in bone
and muscle occurring during an exercise program
effective in counteracting calcium loss to help iden-
tify the influence of such factors as muscle pull,
mechanical stress, piezo-electric stimulation, and
altered circulation on bone demineralization.
o Investigate in space flight, protocols for exercise
that would place stress on weight-bearing bones
equivalent in forces to 4 hours of walking on Earth.
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APPENDIX A
RESEARCH PROJECTS IN BONE DEMINERALIZATION FUNDED IN
FISCAL YEAR 1983 BY THE NASABIOMEDICAL RESEARCH PROGRAM
Investigations in Hormonal Control of Calcium and Bone Metabolism
(199-20-31-03)
Robert M. Neer (Massachusetts General Hospital)
This investigation seeks to understand the role played by the
principal calcium regulatory hormones in the shifts in calcium
metabolism observed during space flight. Using more sensitive
new techniques, stimulation and suppression tests are being
performed to characterize parathyroid hormone and vitamin D
responses that occur in normal subjects as a result of immobi-
lization and glucocorticoid administration.
Determination of Bone Density by Computer Tomography
(199-20-31-10)
Harry K. Genant (University of California)
This task aims to develop sensitive computerized tomographic
techniques for measuring changes in astronauts' bone density
occasioned by space flight. Computerized tomographic tech-
niques for measuring changes in each bone envelope, particu-
larly in the vertebrae, are being developed and will be used
to collect baseline data on human subjects. Using specialized
software in conjunction with a dual-energy X-ray tomography,
cross-sectional data have been collected on numerous subjects
of different ages and of both sexes to determine the normal
variance in vertebral density, and to determine the changes
in density with age. As part of a U.S. - Soviet collaborative
effort, analyses have been performed of tomographic data on
Soviet cosmonauts.
Vitamin D- and Vitamin K-Dependent Regulatory Mechanism in
Calcium Homeostasis (199-20-31-12)
Nitza M. Cintron-Trevino (NASA Johnson Space Center)
The objective of this task is to understand the mechanisms of
action of the vitamin D-derived metabolites and the vitamin
K-dependent calcium-binding proteins (CaBPs) of bone and kid-
ney in effecting calcium homeostasis. Major emphasis is being
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placed on studies of human subjects to determine the relation-
ship between vitamin D status and that of the vitamin K-dependent
CaBPs. The status of each vitamin will be controlled by diet.
Plasma and urine samples will be analyzed for vitamin D
metabolites and vitamin K-dependent CaBPs, among other com-
pounds. Amino acid analyzer methods will be used to determine
the levels of urinary CaBP secretion under varying physiologi-
cal conditions such as bed rest and calcium-associated disorders
such as osteoporosis. Baseline levels for 48 normal human
subjects have been obtained and are found to agree with those
in the literature determined by conventional means.
Clinical Bedrest Research Study (199-20-31-14)
Victor S. Schneider (University of Texas Health Science Center)
Bed-rest simulation of weightlessness is used to study the
effect of a hypogravic situation on the skeletal system. One
specific objective is a study of the effect on bone loss of
"disuse" such as would occur in multiple Space Shuttle trips,
leading to a determination of whether l-g reexposure allows
recovery. A second aim is examination of countermeasures
including mineral supplements, diet modification, pharmaco-
logic agents, and physical modalities. Changes in calcium
absorption and secretion in the gastrointestinal tract during
the first two weeks of bed rest and sources of urinary cal-
cium (skeletal or gastrointestinal) are being studied. Human
subjects are being subjected to anti-orthostatic (head-down)
bed rest to compare changes in calcium metabolism with those
seen in horizontal bed rest. Study is being made of the mini-
mim bed-rest period producing skeletal changes, and the
recovery time needed between short-term bed-rest periods simu-
lating Shuttle missions. Skeletal system changes will be
monitored with an improved computer isotope densitometer
which is already in use and a dual beam photo densitometer
which is now undergoing testing.
Bone Metabolism and Biomechanics (199-20-32-01)
Donald R. Young (NASA Ames Research Center)
Chronically restrained, nonhuman primates were used to inves-
tigate the mechanisms of disuse osteoporosis (increased porosity
and fragility of bones). Histologic and radiographic evidence
indicated that bone loss occurred in the intracortical and
subperiosteal areas of the tibia following prolonged restraint.
The reduction of bone mass resulted in a loss of bending
rigidity in the tibia. Future research will focus on the
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role of parathyroid hormone and aldosterone in acid-base
status and bone loss; study will also be made of the cellular
mechanisms and the time course of recovery associated with
disuse osteoporosis.
Bone Elasticity (199-20-32-02)
Charles R. Steele (Stanford University)
The Steele Oxbridge Bone Stiffness Analyzer developed by NASA
was used for rapid, reproducible, and noninvasive mechanical
evaluation of bone stiffness. Decrease in bending rigidity
of the tibia in the nonhuman primate correlated well with
histologic changes. Animal studies are being conducted to
establish the relationships between new bone formation and
bone stiffness. Human subjects will be used in making non-
invasive tests of bone bending stiffness to determine the
suitability of such tests to monitor changes associated with
fracture healing, senile and disuse osteoporosis, osteo-
porosis associated with metabolic disorders, and during thera-
peutic use of dietary fluoride and phosphate.
Calcium Homeostasis in Altered Gravity (199-20-32-06)
Emily M. Holton (NASA Ames Research Center)
Evidence from prolonged space flight suggested that excessive
steroid secretion from the adrenal cortex or increased sensi-
tivity to steroids by target cells such as osteoblasts (OB),
may contribute to reduced bone formation. Diverse rodent
species exhibited different responses to dexamethasone, a syn-
thetic glucocorticoid, but similar responses to 1,25-dihydroxy-
vitamin D. Receptor binding of vitamin D accelerated with an
increase in growth of rodent OB cultures. Dexamethasone
slowed cell division at all growth phases of mouse OB, while
the effect on rat OB was dependent on the period of growth.
Dexamethasone inhibited OB growth in rats when cells were
sparse, had no effect on intermediate densities, and stimulated
growth in confluent cultures.
Pharmacological Prevention of Bone Loss (199-20-32-14)
Alexander D. Kenny (Texas Tech University)
In testing drugs to block bone loss induced by denervation,
rats were given carbonic anhydrase inhibitors. Results
included a decrease in urinary calcium and no significant
effect in blood acid-base balance in denervated rats. Estra-
diol enhanced acetazolamide's action in the liver of dener-
rated rats. Study will continue to characterize further the
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interrelationships of acetazolamide, estradiol, sex, and age
on carbonic anhydrase activity and bone loss. The ultimate
objective is to discover a therapeutic combination of drugs
which may be administered at doses which minimize side effects.
Mechanisms of Action of Glucocorticosteroids and Fluoride Ion
on the Growing Skeleton (199-20-32-18)
Webster S. Jee (University of Utah School of Medicine)
Effects of glucocorticoids and sodium fluoride (NaF) on skele-
tal tissue were studied. Preliminary data from doses of NaF
given orally to growing rabbits for 15 to 30 days indicated a
decrease in bone formation and longitudinal growth; the higher
the dose, the greater the loss in body weight compared to con-
trols. Cortisol suppressed, and then stopped completely, the
rate of longitudinal growth and formation of the periosteal
bone in rats. Studies will be completed of the effects of
orally administered NaF on bone formation and resorption in
growing rabbits. The cortisol dose-effect study will be com-
pleted on the growing rat model and experiments will be per-
formed on the most effective mode of administering NaF to
rabbits.
Electron Probe Analysis of Trabecular and Cortical Bone
(199-20-32-19)
Theodore L. Bunch (NASA Ames Research Center)
The purpose of this task is to evaluate the microcomposition
and crystalline structure of bone so as to define bone resorp-
tion relative to mineral distribution and crystallinity.
Electron probe analysis has been used to determine in tibial
cortical bone of monkeys the distribution of Ca, P, Mg, Na,
CI, F, S, C, N, O, and K in normal bone, during the development
of disuse osteoporosis, and again during subsequent recovery.
Future efforts will focus on mineral changes occurring in
bone. In addition to electron probe analysis, X-ray and elec-
tron diffraction studies will be employed to characterize the
crystallites of bone in normal subjects and in patients with
osteoporosis. Emphasis will be placed on determining whether
bone collagen loss is preceded by an initial demineralization
of bone.
Biochemical Changes in Bone in a Model of Weightlessness
(199-20-32-20)
Gerald Mechanic (University of North Carolina)
The purpose of this task is to investigate the changes in
collagen chemistry associated with bone mass loss and loss of
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crystallites. Using animal models of disuse osteoporosis,
bones will be analyzed for collagen crosslinks, collagen turn-
over, and tissue levels of cAMP. Mineralized versus nonmin-
eralized collagen content will be determined. Skin samples
from each animal will be subjected to identical analyses to
insure that any effects seen are bone-specific. Both bone
resorption and recovery bone formation will be evaluated.
Results will be correlated with those from other studies
related to alteration of crystallites and of mineral distri-
bution within bone as a result of osteoporosis. The sequence
of events will be defined beginning with demineralization and
extending through subsequent collagen loss.
Identification of an Unknown Humoral A_ent Responsible for
Bone Mobilization (199-20-32-21)
Hector F. DeLuca (University of Wisconsin)
The purpose of this investigation is to determine the nature
and the identity of as yet unidentified factors involved in
bone mobilization. One of the major initial objectives is to
determine whether prolactin or some other pituitary hormone
is responsible for bone mobilization during pregnancy and lac-
tation and which might be involved in bone mobilization during
space flight. Specifically, it is planned to isolate and
identify the factors responsible for bone mobilization during
lactation in vitamin D-deficient rats, and to determine the
quantity of bone loss induced by lactation.
Bone Loss (Tomographic Imaging) (199-20-34-01)
Stanley L. Manatt (Jet Propulsion Laboratory)
This project seeks to understand the various methods for in vivo
bone mineral measurements and to establish which of several
competing approaches best satisfies the needs of NASA. In
addition, ways will be sought to use Jet Propulsion Laboratory
(JPL) expertise in image analysis, photoemission and detection,
and biochemistry in solving the problems of bone mineral loss
and measurement. Two approaches will study computer tomography
(CT). One involves development and testing of a dual photon,
gamma-ray CT system for bone mineral measurements. The
second involves X-ray CT and will assess accuracy and precision
of measurements of bone mineral changes associated with various
metabolic bone disorders, immobilization, and weightlessness.
A third effort is directed toward further improvement of both
single and dual photon gamma-ray absorptiometry through in vivo
and phantom studies; computer algorithms for improved data
analysis are also being developed. Jet Propulsion Laboratory
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personnel will monitor the three efforts described above and
will recommend to NASA the most suitable approach to receive
major effort. To aid in evaluating the three approaches, JPL
has assembled a small dual photon, gadolinium-153 gamma-ray
scanner, capable of operating in both CT and absorptiometry
modes. Results from the scanner will be used to prepare
standards for analysis by the three systems being compared,
to contribute to definition of error models, and to provide
data from which images can be generated.
Feasibility of Improved CT System (199-20-34-02)
Douglas Boyd (Jet Propulsion Laboratory)
This task deals with the development of an improved dual pho-
ton gamma-ray prototype with gadolinium-153 as the radioactive
source. The objective is to demonstrate the accurate measure-
ment of bone mineral density with a prototype device and
verify through analysis and independent testing the potential
for full-scale engineering development of an operational
unit. A breadboard model has been assembled incorporating a
3-Curie, single fan gadolinium-153 source and a cryogenically-
cooled, 15-element germanium detector. The breadboard
includes data acquisition, electronics for pulse counting and
a computer system for data acquisition, reconstruction, and
display. Preliminary tests of contrast and resolving power
have been conducted on phantoms. Continuing tests with phan-
toms will be conducted to define prototype system characteris-
tics and determine final specifications for the complete
system.
CT Determination of Spinal Bone Mineral Content (199-20-34-03)
Harry K. Genant (University of California School of Medicine)
The objective of this task is to develop X-ray Computer
Tomography (CT) methods for accurate and reproducible measure-
ment of vertebral trabecular mineral content. These methods
will be used to measure mineral content and mineral changes
in various metabolic bone disorders including immobilization
and other osteoporoses. In addition, normative data and data
from fracture populations will be obtained for use in pre-
dicting risk of Vertebral fracture. A dual-energy CT method
has been developed for accurate measurement of spinal mineral
content, and phantom validation of the method has been accom-
plished. A joint U.S. - U.S.S.R. effort was initiated to use
CT to measure bone loss in cosmonauts. This effort will con-
tinue, and the CT method will be used in bed-rest studies to
be conducted in collaboration with U.S. scientists. Normative
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single energy CT data from 350 male and female control subjects
have been obtained to define the normal age-related changes
in vertebral mineral content. Normative dual energy data
will be acquired on control subjects to compare with the
single energy results obtained to date. Vertebral autopsy
specimens will be scanned using single and dual energy CT
methods and the mineral content so obtained will be compared
with that resulting from chemical analysis.
Measurement of Trabecular Bone (199-20-34-04)
Richard B. Mazess (University of Wisconsin)
This task aims to decrease the precision errors of single-
(iodine-125) and dual-photon (gadolinium-153) absorptiometry
to provide more sensitive measurements of compact and trabecu-
far bone mass. Sensitivity will be increased by decreasing
the source-detector distance and by increasing the detector
collimation, thereby increasing count rate by a factor of i0
and decreasing precision error from 3_ to i_. Design work
has been performed on a fast amplifier, one with a one-
microsecond pulse and a high slew rate. The system will now
be constructed and tested, with particular attention being
given to corrections for deadtime, scatter, and geometric
factors. It is also planned to investigate the most effec-
tive manner to scan vertebral specimens laterally. By
lateral scanning the centrum can be measured without the
influence of the anterior processes, which may be slower to
change than the centrum.
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APPENDIX B
INFLIGHT EXPERIMENTS PLANNED FOR SPACELAB MISSIONS
Vitamin D Metabolites and Bone Demineralization
Heinrich K. Schnoes, Hector F. DeLuca (University of Wisconsin)
Quantitative measurement of the blood levels of biologically
active vitamin D metabolites of flight crew members of the
Spacelab 2 mission may indicate whether the well known
derangements of calcium metabolism experienced in long-term
missions reflect themselves in any way in a modulation of
vitamin D metabolism to its various metabolites. Since the
biosynthesis of vitamin D metabolites is subject to regula-
tion by several physiological parameters, monitoring these
metabolites under normal and zero-gravity conditions may
yield information about the molecular aspects of the homeo-
static mechanism in weightlessness. Metabolite levels will
be determined by established methods such as competitive pro-
tein binding, high pressure liquid chromatography and gas
liquid chromatography, as well as by newly developed
techniques.
Pathophysiology of Mineral Loss During Spaceflight
Claude D. Arnaud, Christopher E. Cann (University of California)
The purpose of these experiments is to evaluate changes
in calcium homeostasis occurring during space flight in
Spacelab 4 crew members. To determine hormonal effects, the
circulating levels of calcitropic hormones, parathyroid hor-
mone (PTH), calcitonin, and the active vitamin D metabolites
(25-hydroxycholecalciferol, 1,25-dihydroxycholecalciferol,
and 24,25-dihydroxycholecalciferol) will be determined using
sensitive assay systems. PTH determination will include
analysis of the various circulating forms of this hormone
(intact, N-terminal, C-terminal) in an attempt to characterize
any flight-induced changes in its secretion and metabolism.
Serum ionized calcium will also be determined. Direct meas-
urement of intestinal calcium absorption will be done with
the dual-isotope technique, using stable calcium isotopes.
This will determine changes in intestinal handling of calcium
and identify the source of the increased fecal calcium seen
in the Skylab experiments. These changes will be correlated
with measurments o3 1,25-dihydroxycholecalciferol to deter-
mine if there are primary defects in the kidney or intestine.
Analysis of the calcium tracer curves will also provide
information on rates of total body calcium turnover and, by
inference, information about early changes in bone turnover.
7O
Bone, Calcium, and Space Flight
Emily Morey-Holton (NASA Ames Research Center), Christopher E.
Cann (University of California)
Data from rats flown aboard Cosmos biosatellites suggest that
diaphyseal bone formation ceases sometime after the eleventh
day of flight; thus, bone measurements should be made in the
initial flight phase to determine what happens to bone turn-
over during this critical period. The first objective of the
proposed experiment will allow more precise calculation of
the length of flight time required to significantly inhibit
bone formation in both juvenile and adult rats. Tetracycline
labeling of bone, both continuous and pulse labels, will be
one technique used to determine bone turnover. Continuous
tetracycline labeling is necessary to quantify endosteal bone
formation and resorption; intermittent or pulse labels can be
used to assess periosteal formation as no resorption occurs
at this surface in the bone shaft in rats. Using semi-
quantitative measurements such as medullary area and endos-
teal osteoclast nuclei counts, no changes in bone resorption
resulting from exposure to weightlessness have been found to
date. Continuous tetracycline labeling, a quantitative tech-
nique, should provide definitive answers as to whether any
increase in diaphyseal bone resorption does occur. A second
objective of this proposal is thus to determine total skele-
tal formation and resorption and to measure excretion and
intestinal absorption of calcium. 47Ca will be used for the
kinetic studies to be done on days 6-8 of the flight period
while 24 hour urine and fecal samples collected during the
entire flight will be used to calculate calcium balance.
These metabolic studies are expected to show a significant
shift toward negative calcium balance, primarily through
increased fecal excretion. Kinetic analysis will define the
mechanisms behind this loss of calcium. Ground-based infor-
mation will be obtained using a hypodynamic rat model system
developed in this laboratory.
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